BLCA	AZD6244	null	null	14	6	a(ASXL1) 	¬AHNAK  & ¬RB1  & ¬a(GATA3,KLF6,LARP4B,VIM)  & ¬a6p22.3 	 0.3828	Model 1401	GDSC
BLCA	Bleomycin__50_uM	null	null	18	6	MAPK_PI3K-UP 	CDKN2A  | IREB2  | a3p25.2  | MAPK_PI3K-UP 	 0.19291	Model 4101	GDSC
BLCA	CX-5461	null	null	19	6	SMARCA4 	¬ARID1A  & ¬NF2  & ¬a(ASXL1) 	 0.27846	Model 1301	GDSC
BLCA	FTI-277	null	null	19	8	d13q14.2 	ANK3  | FAT1  | NCOR1  | d13q14.2 	 0.5	Model 4101	GDSC
BLCA	GSK690693	null	null	19	5	a3p25.2 	a3p25.2 	 0.5	Model 1101	GDSC
BLCA	OSU-03012	null	null	19	5	MLL3 	TP53  & ¬d(FAT1,IRF2)  & ¬a(SDHC)  & ¬MAPK_PI3K-UP 	 0.29415	Model 1401	GDSC
BLCA	RO-3306	null	null	15	5	ANK3 	ANK3  | MLL3  | NCOR2  | a3p25.2 	 0.52199	Model 4101	GDSC
BLCA	rTRAIL	null	null	18	7	SMARCA4 	SMARCA4 	 0.5	Model 1101	GDSC
BLCA	SB_216763	null	null	12	5	d(CHD9,CNOT1,CYLD,MMP2,NUP93) 	ANK3  | d(CHD9,CNOT1,CYLD,MMP2,NUP93) 	 0.081578	Model 2101	GDSC
BLCA	Tubastatin_A	null	null	19	5	AHNAK 	¬ARID1A  & ¬RB1  & ¬a(ASXL1) 	 0.33911	Model 1301	GDSC
BLCA	Y-39983	null	null	19	6	ANK3 	¬a18p11.32  & a(MYC)   |  CDKN1A  & ¬MAPK_only-UP 	 0.53696	Model 2201	GDSC
BRCA	ABT-263	null	null	43	8	d4p15.2 	d(STK11)  | d13q14.2  | a(BLM,CRTC3,FANCI,IDH2,NR2F2,PCSK6)  | IL-1-UP 	 0.31407	Model 4101	GDSC
BRCA	Afatinib	null	null	44	15	a(CDK12,ERBB2,MED24) 	¬ASXL2  & a(CDK12,ERBB2,MED24)  & ¬PI3K_only-UP 	 0.16119	Model 1301	GDSC
BRCA	Afatinib__rescreen	null	null	46	14	a(CDK12,ERBB2,MED24) 	a(CDK12,ERBB2,MED24) 	 0.022946	Model 1101	GDSC
BRCA	AICAR	null	null	44	5	d13q14.2 	a(FGFR1,WHSC1L1)  & d(FAT1,IRF2) 	 0.51308	Model 1201	GDSC
BRCA	AKT_inhibitor_VIII	null	null	46	9	a(GATA3,KLF6,LARP4B,VIM) 	ARID1A  | a(GATA3,KLF6,LARP4B,VIM) 	 0.44746	Model 2101	GDSC
BRCA	AS601245	null	null	47	7	a(CLTC,PPM1D) 	ASH1L  | ASPM  | MLL3  | a(KRAS) 	 0.4695	Model 4101	GDSC
BRCA	ATRA	null	null	44	5	a(CLTC,PPM1D) 	¬CDH1  & ¬a(TERT)  & a(RAD21)  & ¬d(SYNCRIP,ZNF292) 	 0.1334	Model 1401	GDSC
BRCA	AZD6482	null	null	42	9	a(FOXA1,NKX2-1,PSMA6) 	ARID1A  | CHD4  | EIF4A2  | a(FOXA1,NKX2-1,PSMA6) 	 0.39267	Model 4101	GDSC
BRCA	BIRB_0796	null	null	43	5	a(EGFR) 	FLT3  | PTEN  | d19p12  | VEGF-UP 	 0.53403	Model 4101	GDSC
BRCA	Bleomycin	null	null	47	6	ASH1L 	ASH1L  | a6p24.2 	 0.31987	Model 2101	GDSC
BRCA	BMS-708163	null	null	45	6	d19p12 	d19p12  | VEGF-UP 	 0.20161	Model 2101	GDSC
BRCA	Bryostatin_1	null	null	47	8	a(KRAS) 	¬a(RAD21)  & ¬d(SYNCRIP,ZNF292)  & ¬a(CDK12,ERBB2,MED24) 	 0.48357	Model 1301	GDSC
BRCA	CCT007093	null	null	45	6	d19p12 	¬a(MDM2,NUP107)  & ¬a(TERT)  & a8q24.21  & ¬H2O2-DOWN 	 0.4424	Model 1401	GDSC
BRCA	CH5424802	null	null	46	11	d(ARID1B,MAP3K4,MLLT4) 	CDH1  | CHD4  | KRAS  | a(EGFR) 	 0.47566	Model 4101	GDSC
BRCA	CHIR-99021	null	null	46	5	BRCA2 	BRCA2 	 0.13549	Model 1101	GDSC
BRCA	CP724714	null	null	46	9	a(CDK12,ERBB2,MED24) 	a(CDK12,ERBB2,MED24) 	 0.057861	Model 1101	GDSC
BRCA	CX-5461	null	null	47	16	a1q21.3 	¬a6p24.2  & ¬d(SYNCRIP,ZNF292)  & ¬a(CDK12,ERBB2,MED24)  & ¬d(PABPC3,SACS,ZMYM2) 	 0.41443	Model 1401	GDSC
BRCA	EKB-569	null	null	45	7	a(CLTC,PPM1D) 	¬a(KRAS)  & ¬a(FGFR1,WHSC1L1)  & a(CDK12,ERBB2,MED24) 	 0.15788	Model 1301	GDSC
BRCA	FH535	null	null	47	10	a(CLTC,PPM1D) 	¬ARID1A  & ¬d8p23.2  & ¬d(FAT1,IRF2)  & ¬a1q21.3 	 0.42723	Model 1401	GDSC
BRCA	GSK-1904529A	null	null	47	8	ARID1B 	a(RAD21)  & ¬a8q24.21 	 0.30589	Model 1201	GDSC
BRCA	GSK269962A	null	null	45	5	MACF1 	PTEN  & d(FAT1,IRF2)   |  a(FGFR1,WHSC1L1)  & ¬a(SDHC) 	 0.53115	Model 2201	GDSC
BRCA	GSK690693	null	null	46	24	PIK3CA 	PIK3CA 	 0.35179	Model 1101	GDSC
BRCA	GW-2580	null	null	46	6	CHD4 	¬a(FGFR1,WHSC1L1)  & a(RAD21)  & ¬a(EGFR) 	 0.14587	Model 1301	GDSC
BRCA	GW_441756	null	null	44	5	BAP1 	BAP1 	 0.5	Model 1101	GDSC
BRCA	KIN001-102	null	null	47	10	a(CLTC,PPM1D) 	a(CLTC,PPM1D)  & ¬d(FAT1,IRF2)   |  a8q24.21  & d8p23.2 	 0.44089	Model 2201	GDSC
BRCA	Lapatinib	null	null	13	5	a(CDK12,ERBB2,MED24) 	a(CDK12,ERBB2,MED24) 	 0.003855	Model 1201	GDSC
BRCA	LFM-A13	null	null	47	6	d8p23.3 	¬d(FAS,PTEN)  & ¬a(FGFR1,WHSC1L1)  & d8p23.3 	 0.36552	Model 1301	GDSC
BRCA	LY317615	null	null	47	5	CUX1 	CUX1  | ZFP36L1  | a1q21.3 	 0.49474	Model 3101	GDSC
BRCA	MK-2206	null	null	42	11	APC 	¬BRCA1  & TP53  & ¬d(SYNCRIP,ZNF292)  & ¬d(FAT1,IRF2) 	 0.53219	Model 1401	GDSC
BRCA	MP470	null	null	46	8	a(CLTC,PPM1D) 	GATA3  | MGA  | POLR2B  | PI3K_only-UP 	 0.25217	Model 4101	GDSC
BRCA	NSC-87877	null	null	46	5	ASH1L 	ASH1L 	 0.24314	Model 1101	GDSC
BRCA	PF-4708671	null	null	42	6	AHNAK 	PIK3CA  & ¬a(FGFR1,WHSC1L1)  & ¬d8p23.2  & ¬a20q13.2 	 0.45697	Model 1401	GDSC
BRCA	Phenformin	null	null	46	8	a(CLTC,PPM1D) 	a(CLTC,PPM1D) 	 0.52914	Model 1101	GDSC
BRCA	PIK-93	null	null	47	5	d15q12 	d15q12 	 0.47734	Model 1101	GDSC
BRCA	QL-XI-92	null	null	46	6	CHD4 	CHD4  | d13q14.2 	 0.28375	Model 2101	GDSC
BRCA	QL-XII-61	null	null	22	5	a(CLTC,PPM1D) 	PTEN  & a(FOXA1,NKX2-1,PSMA6)   |  PIK3CA  & a(CLTC,PPM1D) 	 0.3077	Model 2201	GDSC
BRCA	RO-3306	null	null	43	6	a(EGFR) 	APC  | ATR  | d19p12  | PI3K_only-DOWN 	 0.51189	Model 4101	GDSC
BRCA	rTRAIL	null	null	46	7	a7q36.2 	a7q36.2 	 0.38211	Model 1101	GDSC
BRCA	SB52334	null	null	47	8	PI3K_only-UP 	ATR  | CHD4  | FAT1  | H2O2-DOWN 	 0.21337	Model 4101	GDSC
BRCA	Shikonin	null	null	46	5	ASH1L 	ASH1L 	 0.017621	Model 1101	GDSC
BRCA	SL_0101-1	null	null	43	5	PI3K_only-UP 	¬TP53  & ¬a8q24.21   |  a8q24.21  & PI3K_only-UP 	 0.50486	Model 2201	GDSC
BRCA	STF-62247	null	null	47	6	PI3K_only-UP 	¬a(TERT)  & a(RAD21)  & ¬a20q13.2  & ¬a(CCND1) 	 0.33185	Model 1401	GDSC
BRCA	Tipifarnib	null	null	47	5	a(CLTC,PPM1D) 	PIK3CA  & ¬a(FOXA1,NKX2-1,PSMA6) 	 0.29802	Model 1201	GDSC
BRCA	TL-2-105	null	null	47	5	MLL3 	MLL3 	 0.50813	Model 1101	GDSC
BRCA	Tubastatin_A	null	null	47	12	a1q21.3 	¬BRCA1  & ¬d(SYNCRIP,ZNF292)  & a1q21.3 	 0.39813	Model 1301	GDSC
BRCA	WZ3105	null	null	46	5	d8p23.3 	BAP1  | d8p23.3  | TGFB-DOWN 	 0.16305	Model 3101	GDSC
BRCA	Y-39983	null	null	47	10	a1q21.3 	¬a(FOXA1,NKX2-1,PSMA6)  & a1q21.3 	 0.46292	Model 1201	GDSC
COREAD	_5Z_-7-Oxozeaenol	null	null	48	7	a(MET) 	BRWD1  | NCOR1  | d4q31.21  | a(MET) 	 0.35639	Model 4101	GDSC
COREAD	A-770041	null	null	15	5	SMAD4 	ITSN1  | SMAD2  | SMAD4  | Wnt-DOWN 	 0.27524	Model 4101	GDSC
COREAD	ABT-263	null	null	40	5	a(MET) 	a(HSP90AB1,TRERF1)  | a20p11.21  | a8p11.21  | a(MET) 	 0.3399	Model 4101	GDSC
COREAD	AC220	null	null	46	6	IL-1-DOWN 	TCF7L2  | ZC3H11A  | IL-1-DOWN 	 0.24297	Model 3101	GDSC
COREAD	Afatinib	null	null	42	10	d5q12.1 	¬BRAF  & ¬KRAS 	 0.42438	Model 1201	GDSC
COREAD	Afatinib__rescreen	null	null	46	8	a11p15.5 	PTPRU  | a11p15.5  | TNFa-UP  | Wnt-DOWN 	 0.49559	Model 4101	GDSC
COREAD	AS605240	null	null	46	9	d(SMAD4) 	¬BMPR2  & d(SMAD4)   |  ¬PIK3CA  & SMAD4 	 0.3235	Model 2201	GDSC
COREAD	AZD6244	null	null	48	13	BRAF 	¬EGFR  & ¬PIK3CA  & ¬d(CDKN2A)  & ¬VEGF-DOWN 	 0.40854	Model 1401	GDSC
COREAD	Bleomycin	null	null	38	5	ASXL2 	KRAS  & ¬SMAD4  & ¬d(CDKN2A)  & ¬dXp21.3 	 0.41405	Model 1401	GDSC
COREAD	BMS-536924	null	null	48	7	RNF43 	¬CREBBP  & ¬KRAS  & d3p14.2 	 0.38805	Model 1301	GDSC
COREAD	BMS-708163	null	null	45	6	GNAS 	CHD9  | GNAS  | PPP2R1A  | d4q34.3 	 0.45147	Model 4101	GDSC
COREAD	BMS-754807	null	null	38	13	d(SMAD4) 	CHD9  | TCF7L2  | a(FLT3,WASF3) 	 0.45708	Model 3101	GDSC
COREAD	Cetuximab	null	null	42	9	a11p15.5 	¬CREBBP  & ¬a(ING1,IRS2,TFDP1)  & ¬d8p21.1  & VEGF-DOWN 	 0.41638	Model 1401	GDSC
COREAD	CH5424802	null	null	46	10	MLL2 	MLL2  & ¬dXp21.3 	 0.14369	Model 1201	GDSC
COREAD	CI-1040	null	null	41	15	a(STK4) 	¬MLL2  & ¬PIK3CA  & ¬a(CHD4,WNK1)  & ¬d8p21.1 	 0.34296	Model 1401	GDSC
COREAD	CX-5461	null	null	46	29	MLL2 	MLL2 	 0.29906	Model 1101	GDSC
COREAD	Dabrafenib	null	null	44	7	BRAF 	BRAF  | CDC73 	 0.051654	Model 2101	GDSC
COREAD	EKB-569	null	null	46	5	SOX9 	SOX9 	 0.51582	Model 1101	GDSC
COREAD	FR-180204	null	null	46	4	SMARCA4 	MECOM  | SMC1A  | a(MYC) 	 0.55332	Model 3101	GDSC
COREAD	GSK1070916	null	null	44	6	SMARCA4 	¬B2M  & MLL2  & ¬NR4A2 	 0.45967	Model 1301	GDSC
COREAD	GSK690693	null	null	46	10	PTEN 	PTEN 	 0.27906	Model 1101	GDSC
COREAD	HG-5-88-01	null	null	37	5	a(MYC) 	a8p11.21  | a(MYC)  | d2p12 	 0.31841	Model 4101	GDSC
COREAD	I-BET_151	null	null	46	5	SACS 	SACS 	 0.28632	Model 1101	GDSC
COREAD	JNK-9L	null	null	39	5	RNF43 	RNF43  | a(HSP90AB1,TRERF1) 	 0.18232	Model 2101	GDSC
COREAD	JQ1	null	null	48	5	a20p11.21 	¬EP300  & ¬KRAS  & ¬SMAD4 	 0.34216	Model 1301	GDSC
COREAD	KIN001-260	null	null	46	8	PI3K_only-UP 	¬FBXW7  & ¬d(SMAD4)  & d3p14.2 	 0.2648	Model 1301	GDSC
COREAD	LY317615	null	null	46	5	TRIO 	MSR1  | RB1  | d4q31.21  | TGFB-DOWN 	 0.42258	Model 4101	GDSC
COREAD	MP470	null	null	45	7	PBRM1 	PBRM1 	 0.42567	Model 1101	GDSC
COREAD	Nutlin-3a	null	null	40	12	CTNNB1 	CTNNB1  | ¬TP53  | Wnt-DOWN 	 0.05626	Model 3101	GDSC
COREAD	NVP-BHG712	null	null	46	5	¬APC 	¬APC  & KRAS   |  ¬TP53  & a(MYC) 	 0.29498	Model 2201	GDSC
COREAD	OSI-906	null	null	38	11	a(FLT3,WASF3) 	¬BMPR2  & d3p14.2  & ¬VEGF-DOWN 	 0.14578	Model 1301	GDSC
COREAD	OSU-03012	null	null	37	6	ITSN1 	ITSN1  | a(HSP90AB1,TRERF1) 	 0.13722	Model 2101	GDSC
COREAD	PD-0325901	null	null	40	17	a(ING1,IRS2,TFDP1) 	¬BMPR2  & ¬d(CDKN2A)  & ¬VEGF-DOWN 	 0.24935	Model 1301	GDSC
COREAD	PF-562271	null	null	39	5	EGFR 	¬KRAS  & d(SMAD4) 	 0.5	Model 1201	GDSC
COREAD	Phenformin	null	null	46	6	TRIO 	TRIO 	 0.16577	Model 1101	GDSC
COREAD	PLX4720	null	null	40	5	BRAF 	BRAF  & ¬dXp21.3  & d3p14.2 	 0.091703	Model 1301	GDSC
COREAD	PLX4720__rescreen	null	null	45	6	BRAF 	BRAF 	 0.07642	Model 1101	GDSC
COREAD	QL-XII-61	null	null	35	6	FBXW7 	DNMT3A  | FN1  | FOXP1  | SRGAP3 	 0.39588	Model 4101	GDSC
COREAD	RDEA119	null	null	39	12	a(ING1,IRS2,TFDP1) 	¬EGFR  & ¬PIK3CA  & ¬d(CDKN2A)  & ¬VEGF-DOWN 	 0.33747	Model 1401	GDSC
COREAD	RDEA119__rescreen	null	null	47	15	BRAF 	¬B2M  & ¬EP300  & ¬d(CDKN2A)  & ¬d8p21.1 	 0.34	Model 1401	GDSC
COREAD	rTRAIL	null	null	46	19	¬TP53 	BRWD1  | ¬TP53 	 0.3241	Model 2101	GDSC
COREAD	SB590885	null	null	40	8	BRAF 	¬KRAS  & ¬d8p21.1  & ¬dXp21.3  & ¬d(APC) 	 0.25042	Model 1401	GDSC
COREAD	STF-62247	null	null	46	6	a(CHD4,WNK1) 	d6q26  & d3p14.2   |  TCF7L2  & ¬d(APC) 	 0.48772	Model 2201	GDSC
COREAD	Tipifarnib	null	null	38	7	ARID1A 	BMPR2  & ¬SMARCA4 	 0.44383	Model 1201	GDSC
COREAD	Trametinib	null	null	46	26	¬TP53 	¬ATM  & ¬B2M  & ¬PIK3R1  & ¬d(CDKN2A) 	 0.39523	Model 1401	GDSC
COREAD	Tubastatin_A	null	null	46	7	RNF43 	RNF43 	 0.46795	Model 1101	GDSC
COREAD	VX-11e	null	null	46	13	BRAF 	¬CTCF  & ¬d(CDKN2A)  & ¬d(SMAD4)  & ¬VEGF-DOWN 	 0.28207	Model 1401	GDSC
COREAD	XMD14-99	null	null	46	5	SMAD4 	¬MGA  & SMAD4  & ¬a13q22.1 	 0.40941	Model 1301	GDSC
COREAD	Y-39983	null	null	46	18	SMARCA4 	MLL2  & ¬d(APC) 	 0.39496	Model 1201	GDSC
COREAD	ZM-447439	null	null	38	5	RNF43 	¬ARID2  & ¬NR4A2  & RNF43 	 0.31575	Model 1301	GDSC
DLBC	5-Fluorouracil	null	null	27	10	Wnt-UP 	RNF43  | d16q23.1  | JAK-STAT-UP  | Wnt-UP 	 0.2461	Model 4101	GDSC
DLBC	A-770041	null	null	23	10	TLR-UP 	¬PTEN  & TP53  & ¬d16q23.1  & ¬d15q15.1 	 0.29847	Model 1401	GDSC
DLBC	ABT-263	null	null	31	18	CREBBP 	¬PTEN  & TP53  & ¬d16q23.1  & ¬JAK-STAT-UP 	 0.4432	Model 1401	GDSC
DLBC	ABT-869	null	null	27	10	JAK-STAT-UP 	¬MLL2  & TP53  & ¬MAPK_PI3K-DOWN 	 0.38023	Model 1301	GDSC
DLBC	ABT-888	null	null	29	8	ASXL2 	¬MLL2  & ¬PTEN  & TP53  & ¬TLR-UP 	 0.23576	Model 1401	GDSC
DLBC	AC220	null	null	27	10	MAPK_only-DOWN 	H2O2-DOWN  | MAPK_only-DOWN 	 0.49829	Model 2101	GDSC
DLBC	AICAR	null	null	29	9	Wnt-UP 	ASXL2  | Wnt-UP 	 0.35625	Model 2101	GDSC
DLBC	AP-24534	null	null	27	10	CREBBP 	CREBBP  & ¬d15q15.1  & ¬IL-1-DOWN 	 0.34896	Model 1401	GDSC
DLBC	AR-42	null	null	26	12	PTEN 	ASXL2  | MYC  | H2O2-DOWN  | MAPK_only-DOWN 	 0.42699	Model 4101	GDSC
DLBC	AT-7519	null	null	27	10	MAPK_only-DOWN 	JAK-STAT-UP  | MAPK_only-DOWN 	 0.46466	Model 2101	GDSC
DLBC	ATRA	null	null	29	7	MYC 	MYC  | PTEN 	 0.079616	Model 2101	GDSC
DLBC	AV-951	null	null	27	12	ASXL2 	ASXL2 	 0.5	Model 1101	GDSC
DLBC	AZD-0530	null	null	25	5	CREBBP 	¬ARID1A  & CREBBP 	 0.42352	Model 1201	GDSC
DLBC	AZD6482	null	null	27	8	MAPK_only-DOWN 	EP300  | MAPK_only-DOWN 	 0.25503	Model 2101	GDSC
DLBC	AZD7762	null	null	29	7	MAPK_only-DOWN 	MYC  | MAPK_only-DOWN 	 0.33029	Model 2101	GDSC
DLBC	AZD8055	null	null	31	16	MAPK_only-DOWN 	MAPK_only-DOWN 	 0.30861	Model 1101	GDSC
DLBC	BAY_61-3606	null	null	27	6	MAPK_only-DOWN 	CREBBP  & ¬d15q15.1   |  ¬TP53  & Wnt-UP 	 0.17956	Model 2201	GDSC
DLBC	Bicalutamide	null	null	27	10	Wnt-UP 	Wnt-UP 	 0.42476	Model 1101	GDSC
DLBC	BIRB_0796	null	null	28	8	d10p12.2 	MLL2  & ¬d(CDKN2A)   |  ¬TP53  & ¬d(CDKN2A) 	 0.38021	Model 2201	GDSC
DLBC	BIX02189	null	null	27	9	Wnt-UP 	Wnt-UP  & ¬MAPK_only-DOWN   |  CREBBP  & ¬TP53 	 0.55073	Model 2201	GDSC
DLBC	BMS-345541	null	null	27	13	EP300 	EP300 	 0.43239	Model 1101	GDSC
DLBC	BMS-708163	null	null	27	12	ASXL2 	¬MLL2  & ¬d16q23.1  & ¬TLR-UP  & ¬MAPK_PI3K-DOWN 	 0.43961	Model 1401	GDSC
DLBC	Bosutinib	null	null	29	6	MAPK_only-DOWN 	¬MLL2  & ¬PTEN  & TP53  & ¬JAK-STAT-UP 	 0.18384	Model 1401	GDSC
DLBC	Bryostatin_1	null	null	27	6	Wnt-UP 	CREBBP  & d(CDKN2A)   |  MLL2  & TP53 	 0.59222	Model 2201	GDSC
DLBC	BX-795	null	null	31	7	MAPK_only-DOWN 	RNF43  | MAPK_only-DOWN 	 0.46617	Model 2101	GDSC
DLBC	BX-912	null	null	27	12	Wnt-UP 	ARID1A  | EP300  | MYC  | MAPK_only-DOWN 	 0.51581	Model 4101	GDSC
DLBC	CAL-101	null	null	27	15	EP300 	EP300  | Wnt-UP 	 0.16505	Model 2101	GDSC
DLBC	Camptothecin	null	null	29	7	Wnt-UP 	Wnt-UP 	 0.42028	Model 1101	GDSC
DLBC	CAY10603	null	null	27	13	MLL2 	MLL2  | H2O2-DOWN 	 0.32909	Model 2101	GDSC
DLBC	CCT007093	null	null	27	7	ASXL2 	¬ARID1A  & ¬MLL2  & TP53  & ¬TLR-UP 	 0.22679	Model 1401	GDSC
DLBC	CEP-701	null	null	29	10	MAPK_only-DOWN 	¬EP300  & MAPK_only-DOWN  & ¬PI3K_only-DOWN 	 0.50503	Model 1301	GDSC
DLBC	CGP-082996	null	null	23	6	B2M 	B2M 	 0.5	Model 1101	GDSC
DLBC	CH5424802	null	null	27	11	Wnt-UP 	¬CREBBP  & ¬TP53  & ¬d16q23.1  & ¬TLR-UP 	 0.29775	Model 1401	GDSC
DLBC	CHIR-99021	null	null	28	7	d15q15.1 	d15q15.1  | Wnt-UP 	 0.5449	Model 2101	GDSC
DLBC	CMK	null	null	23	7	CREBBP 	¬ARID1A  & CREBBP 	 0.4357	Model 1201	GDSC
DLBC	CP466722	null	null	27	7	Wnt-UP 	B2M  | CREBBP  | Wnt-UP  | H2O2-DOWN 	 0.47413	Model 4101	GDSC
DLBC	CP724714	null	null	27	10	Wnt-UP 	¬EP300  & ¬MLL2  & ¬d16q23.1  & ¬TLR-UP 	 0.32655	Model 1401	GDSC
DLBC	CUDC-101	null	null	26	14	MLL2 	ASXL2  | MLL2  | H2O2-DOWN 	 0.35447	Model 3101	GDSC
DLBC	Cyclopamine	null	null	25	8	CREBBP 	¬ARID1A  & CREBBP  & ¬d(CIITA)  & ¬d15q15.1 	 0.41535	Model 1401	GDSC
DLBC	Cytarabine	null	null	29	7	MLL2 	MLL2  | RNF43 	 0.27537	Model 2101	GDSC
DLBC	Dabrafenib	null	null	29	5	Wnt-UP 	¬TP53  & ¬TLR-UP  & ¬MAPK_PI3K-DOWN 	 0.35808	Model 1301	GDSC
DLBC	Dasatinib	null	null	22	7	CREBBP 	CREBBP 	 0.281	Model 1101	GDSC
DLBC	DMOG	null	null	28	9	Wnt-UP 	d16q23.1  | Wnt-UP  | H2O2-DOWN 	 0.34898	Model 3101	GDSC
DLBC	EKB-569	null	null	27	7	d(CDKN2A) 	d(CDKN2A)  & ¬TLR-UP   |  ASXL2 	 0.49571	Model 2201	GDSC
DLBC	Embelin	null	null	27	5	Wnt-UP 	Wnt-UP 	 0.29471	Model 1101	GDSC
DLBC	Erlotinib	null	null	25	5	B2M 	¬MLL2  & ¬PTEN  & ¬TLR-UP  & ¬MAPK_PI3K-DOWN 	 0.27965	Model 1401	GDSC
DLBC	Etoposide	null	null	28	5	d(CDKN2A) 	¬TP53  & ¬d16q23.1  & ¬TLR-UP  & ¬PI3K_only-DOWN 	 0.38371	Model 1401	GDSC
DLBC	EX-527	null	null	27	11	Wnt-UP 	ASXL2  | JAK-STAT-UP  | Wnt-UP  | H2O2-DOWN 	 0.36938	Model 4101	GDSC
DLBC	FMK	null	null	26	10	MAPK_only-DOWN 	ARID1A  | EP300  | JAK-STAT-UP  | Wnt-UP 	 0.18752	Model 4101	GDSC
DLBC	GDC0941	null	null	31	11	MAPK_only-DOWN 	MAPK_only-DOWN  & ¬PI3K_only-DOWN 	 0.26539	Model 1201	GDSC
DLBC	GNF-2	null	null	23	5	ASXL2 	¬MLL2  & ¬PTEN  & ¬d16q23.1  & ¬TLR-UP 	 0.050941	Model 1401	GDSC
DLBC	GSK1070916	null	null	23	8	MLL2 	ARID1A  | MYC  | PTEN 	 0.57557	Model 3101	GDSC
DLBC	GSK-1904529A	null	null	27	5	ASXL2 	¬MLL2  & ¬PTEN  & ¬TLR-UP  & ¬MAPK_PI3K-DOWN 	 0.16456	Model 1401	GDSC
DLBC	GSK2126458	null	null	27	8	EP300 	ASXL2  | EP300  | Wnt-UP 	 0.40988	Model 3101	GDSC
DLBC	GSK269962A	null	null	29	5	MAPK_only-DOWN 	¬TP53  & ¬d(CDKN2A)   |  ¬EP300  & MAPK_only-DOWN 	 0.32797	Model 2201	GDSC
DLBC	GSK429286A	null	null	27	11	MAPK_PI3K-DOWN 	MYC  | Wnt-UP  | H2O2-DOWN  | MAPK_PI3K-DOWN 	 0.47532	Model 4101	GDSC
DLBC	GW-2580	null	null	27	12	d16q23.1 	¬TP53  & ¬d10p12.2  & ¬MAPK_PI3K-DOWN 	 0.39996	Model 1301	GDSC
DLBC	GW_441756	null	null	29	6	MYC 	¬CREBBP  & TLR-UP   |  MLL2  & d(CDKN2A) 	 0.51759	Model 2201	GDSC
DLBC	HG-6-64-1	null	null	28	6	H2O2-DOWN 	H2O2-DOWN  & ¬IL-1-DOWN 	 0.5	Model 1201	GDSC
DLBC	I-BET_151	null	null	27	19	MLL2 	EP300  & ¬d(CIITA)   |  ¬TP53  & ¬TLR-UP 	 0.34386	Model 2201	GDSC
DLBC	IOX2	null	null	29	11	d15q15.1 	¬ARID1A  & CREBBP 	 0.28218	Model 1201	GDSC
DLBC	IPA-3	null	null	27	6	MAPK_only-DOWN 	MAPK_only-DOWN 	 0.56686	Model 1101	GDSC
DLBC	JNK_Inhibitor_VIII	null	null	31	6	MAPK_only-DOWN 	¬CREBBP  & ¬PTEN  & TP53  & ¬TLR-UP 	 0.40103	Model 1401	GDSC
DLBC	JQ12	null	null	28	5	H2O2-DOWN 	ASXL2  | Wnt-UP  | H2O2-DOWN 	 0.53778	Model 4101	GDSC
DLBC	JQ1	null	null	28	16	B2M 	B2M 	 0.5	Model 1101	GDSC
DLBC	JW-7-24-1	null	null	27	14	EP300 	ASXL2  & ¬RNF43   |  EP300 	 0.35367	Model 2201	GDSC
DLBC	KIN001-102	null	null	27	6	EP300 	¬d(CDKN2A)  & Wnt-UP   |  EP300  & ¬IL-1-DOWN 	 0.1372	Model 2201	GDSC
DLBC	KIN001-135	null	null	25	8	MAPK_only-DOWN 	¬MLL2  & ¬d16q23.1  & ¬TLR-UP  & ¬MAPK_PI3K-DOWN 	 0.42299	Model 1401	GDSC
DLBC	KIN001-236	null	null	27	17	MAPK_only-DOWN 	¬d16q23.1  & ¬d(CDKN2A)  & ¬d15q15.1  & ¬TLR-UP 	 0.42287	Model 1401	GDSC
DLBC	KIN001-244	null	null	27	12	MAPK_only-DOWN 	¬RNF43  & TP53  & ¬H2O2-DOWN  & ¬MAPK_PI3K-DOWN 	 0.43138	Model 1401	GDSC
DLBC	KIN001-260	null	null	27	21	MLL2 	MLL2  | Wnt-UP 	 0.3386	Model 2101	GDSC
DLBC	KIN001-270	null	null	27	16	Wnt-UP 	Wnt-UP 	 0.45828	Model 1101	GDSC
DLBC	KU-55933	null	null	31	8	MAPK_only-DOWN 	MAPK_only-DOWN 	 0.53741	Model 1101	GDSC
DLBC	LAQ824	null	null	27	7	MAPK_only-DOWN 	d16q23.1  | MAPK_only-DOWN 	 0.54106	Model 2101	GDSC
DLBC	Lenalidomide	null	null	29	9	d16q23.1 	¬MLL2  & ¬PTEN  & ¬TLR-UP 	 0.17356	Model 1301	GDSC
DLBC	LFM-A13	null	null	27	7	d16q23.1 	¬ARID1A  & d16q23.1 	 0.51618	Model 1201	GDSC
DLBC	LY317615	null	null	27	5	MAPK_only-DOWN 	MAPK_only-DOWN 	 0.20526	Model 1101	GDSC
DLBC	Masitinib	null	null	27	5	ARID1A 	ARID1A 	 0.50234	Model 1101	GDSC
DLBC	Methotrexate	null	null	29	13	RNF43 	RNF43 	 0.46081	Model 1101	GDSC
DLBC	MK-2206	null	null	31	12	MAPK_only-DOWN 	PTEN  & ¬MAPK_only-DOWN   |  MAPK_only-DOWN  & ¬PI3K_only-DOWN 	 0.27831	Model 2201	GDSC
DLBC	MP470	null	null	26	8	d(CDKN2A) 	¬TP53  & ¬TLR-UP 	 0.175	Model 1201	GDSC
DLBC	MS-275	null	null	27	6	JAK-STAT-UP 	¬MLL2  & ¬TP53  & ¬TLR-UP 	 0.17574	Model 1301	GDSC
DLBC	NG-25	null	null	27	12	MAPK_only-DOWN 	MAPK_only-DOWN   |  ¬d10p12.2  & Wnt-UP 	 0.23106	Model 2201	GDSC
DLBC	Nilotinib	null	null	29	10	MAPK_only-DOWN 	MAPK_only-DOWN 	 0.27999	Model 1101	GDSC
DLBC	NPK76-II-72-1	null	null	27	10	RNF43 	¬EP300  & PTEN   |  MLL2  & ¬MAPK_PI3K-DOWN 	 0.45859	Model 2201	GDSC
DLBC	NSC-87877	null	null	28	6	d15q15.1 	¬MLL2  & ¬d16q23.1  & ¬TLR-UP  & ¬MAPK_only-DOWN 	 0.18762	Model 1401	GDSC
DLBC	NU-7441	null	null	31	9	MAPK_only-DOWN 	EP300  | MYC  | d15q15.1  | MAPK_only-DOWN 	 0.41105	Model 4101	GDSC
DLBC	Nutlin-3a	null	null	31	19	¬TP53 	¬TP53 	 0.052532	Model 1301	GDSC
DLBC	NVP-BEZ235	null	null	31	6	MAPK_only-DOWN 	H2O2-DOWN  | MAPK_only-DOWN 	 0.13405	Model 2101	GDSC
DLBC	NVP-BHG712	null	null	27	13	MAPK_only-DOWN 	ASXL2  | Wnt-UP  | MAPK_only-DOWN 	 0.39713	Model 3101	GDSC
DLBC	Olaparib	null	null	29	7	Wnt-UP 	ARID1A  | ASXL2  | B2M  | Wnt-UP 	 0.37429	Model 4101	GDSC
DLBC	OSI-027	null	null	27	10	MLL2 	ASXL2  | MLL2 	 0.35518	Model 2101	GDSC
DLBC	OSI-930	null	null	27	12	MAPK_PI3K-DOWN 	ASXL2  | Wnt-UP  | H2O2-DOWN  | MAPK_PI3K-DOWN 	 0.44514	Model 4101	GDSC
DLBC	PAC-1	null	null	27	7	Wnt-UP 	ARID1A  | d16q23.1  | Wnt-UP 	 0.4364	Model 3101	GDSC
DLBC	Parthenolide	null	null	25	10	MAPK_only-DOWN 	¬TP53  & ¬d16q23.1  & ¬TLR-UP  & ¬IL-1-DOWN 	 0.36532	Model 1401	GDSC
DLBC	PD-173074	null	null	31	5	d16q23.1 	¬MLL2  & ¬PTEN  & ¬TLR-UP  & ¬MAPK_PI3K-DOWN 	 0.26992	Model 1401	GDSC
DLBC	PFI-1	null	null	29	6	Wnt-UP 	H2O2-DOWN   |  ¬TP53  & ¬TLR-UP 	 0.39605	Model 2201	GDSC
DLBC	PHA-793887	null	null	27	17	Wnt-UP 	¬TP53  & ¬TLR-UP   |  EP300 	 0.36628	Model 2201	GDSC
DLBC	Phenformin	null	null	27	10	Wnt-UP 	¬d16q23.1  & Wnt-UP   |  MLL2  & MAPK_PI3K-DOWN 	 0.16406	Model 2201	GDSC
DLBC	PI-103	null	null	26	10	EP300 	ASXL2  | EP300  | Wnt-UP 	 0.42633	Model 3101	GDSC
DLBC	PIK-93	null	null	27	16	EP300 	TP53  & ¬d16q23.1  & ¬d15q15.1  & ¬IL-1-DOWN 	 0.2972	Model 1401	GDSC
DLBC	piperlongumine	null	null	29	5	Wnt-UP 	¬CREBBP  & ¬TP53  & ¬d16q23.1  & ¬TLR-UP 	 0.22932	Model 1401	GDSC
DLBC	PLX4720__rescreen	null	null	29	5	d16q23.1 	d16q23.1  | Wnt-UP 	 0.36574	Model 2101	GDSC
DLBC	PXD101_Belinostat	null	null	26	11	MLL2 	¬CREBBP  & ¬PTEN  & TP53  & ¬d16q23.1 	 0.33885	Model 1401	GDSC
DLBC	QL-X-138	null	null	27	11	ASXL2 	MLL2  & ¬d16q23.1  & ¬d10p12.2 	 0.2952	Model 1401	GDSC
DLBC	QL-XI-92	null	null	27	20	d(CDKN2A) 	d(CDKN2A)  | MAPK_only-DOWN 	 0.473	Model 2101	GDSC
DLBC	Rapamycin	null	null	21	7	B2M 	¬PTEN  & TP53  & ¬d15q15.1 	 0.37383	Model 1301	GDSC
DLBC	Roscovitine	null	null	26	7	B2M 	¬CREBBP  & ¬MLL2  & ¬PTEN  & ¬TLR-UP 	 0.33043	Model 1401	GDSC
DLBC	rTRAIL	null	null	29	12	Wnt-UP 	¬CREBBP  & ¬PTEN  & TP53 	 0.22439	Model 1301	GDSC
DLBC	Ruxolitinib	null	null	27	16	Wnt-UP 	¬MLL2  & ¬TLR-UP  & ¬MAPK_only-DOWN  & ¬MAPK_PI3K-DOWN 	 0.48142	Model 1401	GDSC
DLBC	SB_216763	null	null	29	5	MAPK_only-DOWN 	¬PTEN  & ¬d(CIITA)  & MAPK_only-DOWN  & ¬PI3K_only-DOWN 	 0.16437	Model 1401	GDSC
DLBC	SB-505124	null	null	29	9	Wnt-UP 	¬MLL2  & ¬RNF43  & ¬TLR-UP  & ¬MAPK_PI3K-DOWN 	 0.32765	Model 1401	GDSC
DLBC	SB52334	null	null	27	5	d(CDKN2A) 	MLL2  & d(CDKN2A)   |  PTEN  & ¬TP53 	 0.19813	Model 2201	GDSC
DLBC	SB590885	null	null	31	7	MYC 	d10p12.2  & ¬TLR-UP 	 0.52989	Model 1201	GDSC
DLBC	SGC0946	null	null	29	11	EP300 	¬CREBBP  & ¬MLL2  & ¬d16q23.1  & ¬TLR-UP 	 0.32834	Model 1401	GDSC
DLBC	Shikonin	null	null	28	7	H2O2-DOWN 	MYC  | d(CIITA)  | Wnt-UP  | H2O2-DOWN 	 0.54101	Model 4101	GDSC
DLBC	SL_0101-1	null	null	31	10	MAPK_only-DOWN 	¬PTEN  & TP53  & ¬d16q23.1  & ¬TLR-UP 	 0.36666	Model 1401	GDSC
DLBC	STF-62247	null	null	27	17	Wnt-UP 	RNF43  | Wnt-UP  | H2O2-DOWN  | MAPK_only-DOWN 	 0.35589	Model 4101	GDSC
DLBC	T0901317	null	null	27	15	MYC 	¬CREBBP  & ¬TP53  & ¬TLR-UP 	 0.3682	Model 1301	GDSC
DLBC	TAK-715	null	null	27	14	H2O2-DOWN 	JAK-STAT-UP  | H2O2-DOWN  | MAPK_only-DOWN 	 0.53282	Model 3101	GDSC
DLBC	Tamoxifen	null	null	29	11	CREBBP 	CREBBP  & ¬d(CIITA)  & ¬IL-1-DOWN  & ¬PI3K_only-DOWN 	 0.41658	Model 1401	GDSC
DLBC	Temozolomide	null	null	29	12	d16q23.1 	RNF43  | d16q23.1  | Wnt-UP 	 0.33128	Model 3101	GDSC
DLBC	Temsirolimus	null	null	29	13	MAPK_only-DOWN 	d15q15.1  | MAPK_only-DOWN 	 0.24363	Model 2101	GDSC
DLBC	TG101348	null	null	27	11	Wnt-UP 	¬TP53  & ¬d10p12.2  & ¬TLR-UP  & ¬PI3K_only-DOWN 	 0.35973	Model 1401	GDSC
DLBC	THZ-2-102-1	null	null	27	6	JAK-STAT-UP 	TP53  & TLR-UP   |  ARID1A  & ¬MAPK_PI3K-DOWN 	 0.49402	Model 2201	GDSC
DLBC	THZ-2-49	null	null	27	5	d(CDKN2A) 	ARID1A  | MYC  | d(CIITA)  | JAK-STAT-UP 	 0.50961	Model 4101	GDSC
DLBC	Tipifarnib	null	null	27	6	d16q23.1 	d16q23.1 	 0.14071	Model 1101	GDSC
DLBC	TL-1-85	null	null	27	12	MAPK_only-DOWN 	ASXL2  | Wnt-UP  | MAPK_only-DOWN 	 0.23617	Model 3101	GDSC
DLBC	TL-2-105	null	null	27	6	MAPK_PI3K-DOWN 	CREBBP  | H2O2-DOWN  | MAPK_PI3K-DOWN 	 0.59963	Model 3101	GDSC
DLBC	TPCA-1	null	null	27	13	d(CDKN2A) 	¬TP53  & ¬TLR-UP 	 0.47557	Model 1201	GDSC
DLBC	Tubastatin_A	null	null	26	21	MLL2 	MLL2  | MAPK_only-DOWN 	 0.22662	Model 2101	GDSC
DLBC	UNC0638	null	null	29	5	d15q15.1 	d15q15.1  | Wnt-UP 	 0.42776	Model 2101	GDSC
DLBC	UNC1215	null	null	29	14	Wnt-UP 	¬d16q23.1  & ¬d(CDKN2A)  & ¬JAK-STAT-UP  & ¬MAPK_PI3K-DOWN 	 0.45517	Model 1401	GDSC
DLBC	Vinblastine	null	null	29	8	Wnt-UP 	¬MLL2  & ¬TP53  & ¬TLR-UP 	 0.57808	Model 1301	GDSC
DLBC	Vismodegib	null	null	29	10	MAPK_only-DOWN 	MAPK_only-DOWN 	 0.21041	Model 1101	GDSC
DLBC	VNLG124	null	null	27	16	Wnt-UP 	¬CREBBP  & TP53  & ¬TLR-UP 	 0.47125	Model 1301	GDSC
DLBC	Vorinostat	null	null	29	8	B2M 	ASXL2  | B2M  | MYC 	 0.48271	Model 4101	GDSC
DLBC	VX-11e	null	null	27	7	ARID1A 	ARID1A  | ASXL2  | d(CIITA)  | Wnt-UP 	 0.316	Model 4101	GDSC
DLBC	VX-680	null	null	22	6	ARID1A 	ARID1A  | ASXL2  | d16q23.1 	 0.52592	Model 4101	GDSC
DLBC	VX-702	null	null	29	11	d(CIITA) 	¬MLL2  & ¬PTEN  & ¬TLR-UP 	 0.36506	Model 1301	GDSC
DLBC	WH-4-023	null	null	23	6	CREBBP 	¬ARID1A  & CREBBP  & ¬d15q15.1 	 0.26277	Model 1301	GDSC
DLBC	WZ-1-84	null	null	23	5	MAPK_only-DOWN 	CREBBP  & TP53  & ¬d15q15.1  & ¬IL-1-DOWN 	 0.28589	Model 1401	GDSC
DLBC	WZ3105	null	null	27	5	JAK-STAT-UP 	JAK-STAT-UP 	 0.5	Model 1101	GDSC
DLBC	XL-184	null	null	27	5	ASXL2 	ASXL2   |  TP53  & MAPK_only-DOWN 	 0.37433	Model 2201	GDSC
DLBC	XMD13-2	null	null	27	12	MLL2 	¬TP53  & ¬TLR-UP  & ¬Wnt-UP 	 0.29567	Model 1301	GDSC
DLBC	XMD14-99	null	null	27	18	ARID1A 	¬TP53  & ¬TLR-UP 	 0.29102	Model 1201	GDSC
DLBC	XMD15-27	null	null	27	13	Wnt-UP 	¬TP53  & ¬TLR-UP  & ¬MAPK_PI3K-DOWN 	 0.41322	Model 1301	GDSC
DLBC	XMD8-85	null	null	25	6	MAPK_only-DOWN 	¬d(CIITA)  & MAPK_only-DOWN  & ¬PI3K_only-DOWN 	 0.54946	Model 1301	GDSC
DLBC	YK_4-279	null	null	26	5	RNF43 	MLL2  & ¬MYC  & ¬d(CDKN2A)  & ¬MAPK_PI3K-DOWN 	 0.47344	Model 1401	GDSC
DLBC	YM201636	null	null	27	10	MAPK_only-DOWN 	ASXL2  | MYC  | MAPK_only-DOWN 	 0.3202	Model 3101	GDSC
DLBC	Zibotentan_ZD4054	null	null	27	11	EP300 	¬PTEN  & TP53  & ¬d16q23.1 	 0.38652	Model 1301	GDSC
DLBC	ZM-447439	null	null	31	7	MAPK_only-DOWN 	¬TP53  & ¬d16q23.1  & ¬d(CDKN2A)  & ¬TLR-UP 	 0.42159	Model 1401	GDSC
DLBC	ZSTK474	null	null	27	13	MAPK_only-DOWN 	MAPK_only-DOWN 	 0.37801	Model 1101	GDSC
ESCA	Afatinib	null	null	31	18	a(ERBB2) 	NOTCH1  | a(KRAS)  | a(ERBB2) 	 0.32998	Model 3101	GDSC
ESCA	Afatinib__rescreen	null	null	32	14	a(EGFR) 	¬BAP1  & a(ERBB2)   |  NOTCH1  & ¬a(CCND1,CTTN) 	 0.28697	Model 2201	GDSC
ESCA	AICAR	null	null	30	5	NOTCH1 	NOTCH1  & ¬d20p12.1 	 0.01457	Model 1201	GDSC
ESCA	AS601245	null	null	27	6	NOTCH1 	Wnt-DOWN   |  NOTCH1  & ¬RB1 	 0.32021	Model 2201	GDSC
ESCA	AZD-0530	null	null	11	6	NOTCH1 	¬RTN4  & ¬PIK3CA  & ¬d2q22.1 	 0.19567	Model 1401	GDSC
ESCA	BIRB_0796	null	null	30	5	d20p12.1 	d20p12.1  & ¬a(EGFR)  & ¬d(PAX5) 	 0.127	Model 1301	GDSC
ESCA	BMS-345541	null	null	35	5	d20p12.1 	d20p12.1  | VEGF-DOWN 	 0.41607	Model 2101	GDSC
ESCA	BMS-708163	null	null	35	6	d20p12.1 	d20p12.1  & ¬d16q23.1 	 0.5	Model 1201	GDSC
ESCA	Cetuximab	null	null	32	11	d2q22.1 	d2q22.1  & ¬Wnt-UP 	 0.3361	Model 1201	GDSC
ESCA	CH5424802	null	null	35	7	a(EGFR) 	¬SMAD2  & ¬a(FGFR1,WHSC1L1)  & ¬d2q22.1  & a(ERBB2) 	 0.42605	Model 1401	GDSC
ESCA	CP724714	null	null	35	10	a(ERBB2) 	a(ERBB2)  & ¬TGFB-DOWN 	 0.16061	Model 1201	GDSC
ESCA	CX-5461	null	null	35	18	d20p12.1 	d20p12.1 	 0.27789	Model 1101	GDSC
ESCA	Docetaxel	null	null	31	6	CREBBP 	¬BAP1  & a(CCND1,CTTN)  & ¬ARID2  & ¬Wnt-UP 	 0.40666	Model 1401	GDSC
ESCA	EKB-569	null	null	35	8	Wnt-DOWN 	STK11  | SMAD4  | Wnt-DOWN 	 0.23878	Model 3101	GDSC
ESCA	Epothilone_B	null	null	27	7	PI3K_only-UP 	CREBBP  & ¬RB1   |  ¬a(ERBB2)  & PI3K_only-UP 	 0.50364	Model 2201	GDSC
ESCA	FR-180204	null	null	35	5	d(PAX5) 	¬SMAD2  & ¬a(CCND1,CTTN)  & ¬a(EGFR)  & a(ERBB2) 	 0.37169	Model 1401	GDSC
ESCA	Gefitinib	null	null	31	15	a(EGFR) 	a(EGFR) 	 0.30349	Model 1101	GDSC
ESCA	GSK-1904529A	null	null	27	5	RTN4 	a(CCND1,CTTN)  & ¬a(EGFR)  & ¬a(ERBB2)  & ¬d16q23.1 	 0.43539	Model 1401	GDSC
ESCA	GSK2126458	null	null	35	6	d16q23.1 	TLR-DOWN  | Wnt-DOWN 	 0.50863	Model 2101	GDSC
ESCA	GSK-650394	null	null	27	7	PI3K_only-UP 	KDM6A  | PI3K_only-UP 	 0.41342	Model 2101	GDSC
ESCA	GSK690693	null	null	35	14	d20p12.1 	d20p12.1  | Wnt-DOWN 	 0.36777	Model 2101	GDSC
ESCA	KIN001-055	null	null	35	7	Wnt-DOWN 	MACF1  | FAT1  | TLR-DOWN  | Wnt-DOWN 	 0.40103	Model 4101	GDSC
ESCA	KIN001-260	null	null	35	6	d20p12.1 	¬a7q31.1  & ¬a(CCND1,CTTN)  & ¬a(EGFR)  & ¬PIK3CA 	 0.47895	Model 1401	GDSC
ESCA	MPS-1-IN-1	null	null	35	5	MACF1 	MACF1 	 0.53042	Model 1101	GDSC
ESCA	NSC-87877	null	null	27	5	BAP1 	¬CREBBP  & a(EGFR)  & ¬NFE2L2 	 0.35201	Model 1301	GDSC
ESCA	Obatoclax_Mesylate	null	null	27	5	PI3K_only-UP 	¬CDKN2A  & PI3K_only-UP 	 0.50444	Model 1401	GDSC
ESCA	OSI-906	null	null	26	6	NOTCH1 	NOTCH1  | BAP1 	 0.14757	Model 2101	GDSC
ESCA	PD-0325901	null	null	31	5	VEGF-DOWN 	d20p12.1  & ¬d(PAX5)   |  ¬a(KRAS)  & VEGF-DOWN 	 0.3361	Model 2201	GDSC
ESCA	PF-562271	null	null	26	6	KDM6A 	ARID2  | KDM6A  | NFE2L2 	 0.23061	Model 3101	GDSC
ESCA	QL-XI-92	null	null	35	8	d16q23.1 	d20p12.1  | BAP1  | Wnt-DOWN 	 0.23176	Model 3101	GDSC
ESCA	rTRAIL	null	null	33	10	a(ERBB2) 	¬d2q22.1  & a(ERBB2) 	 0.18488	Model 1201	GDSC
ESCA	Tamoxifen	null	null	34	6	NCOR1 	¬EP300  & ¬d(PAX5)  & d2q22.1  & ¬d16q23.1 	 0.16723	Model 1401	GDSC
ESCA	Trametinib	null	null	32	8	a(EGFR) 	a(EGFR)  | TGFB-DOWN 	 0.44164	Model 2101	GDSC
ESCA	WZ-1-84	null	null	11	5	¬a(CCND1,CTTN) 	¬RTN4  & ¬PIK3CA  & ¬d2q22.1 	 0.2484	Model 1301	GDSC
ESCA	XAV_939	null	null	33	5	TGFB-DOWN 	a(CCND1,CTTN)  & d2q22.1 	 0.38704	Model 1201	GDSC
ESCA	XL-184	null	null	35	5	a7q31.1 	¬a(CCND1,CTTN)  & d16q23.1 	 0.5112	Model 1201	GDSC
ESCA	XMD15-27	null	null	35	5	d16q23.1 	¬a7q31.1  & d16q23.1 	 0.17613	Model 1201	GDSC
ESCA	Y-39983	null	null	35	9	d(PAX5) 	d(PAX5)  | KDM6A 	 0.38327	Model 2101	GDSC
GBM	A-770041	null	null	12	7	¬PTEN 	¬BRAF  & ¬PTEN 	 0.24148	Model 1201	GDSC
GBM	ABT-869	null	null	35	7	a(MDM2,NUP107) 	KDM6A  | a(MDM2,NUP107)  | d(ANK3),d10q22.1 	 0.37126	Model 3101	GDSC
GBM	AMG-706	null	null	33	8	d10p12.1 	d18p11.32  | a(FIP1L1,PDGFRA)  | a(MDM2,NUP107)  | d10p12.1 	 0.31964	Model 4101	GDSC
GBM	AP-24534	null	null	31	6	a(CDK4) 	a(CDK4)  | IL-1-UP 	 0.47792	Model 2101	GDSC
GBM	AV-951	null	null	35	6	a(AKAP9) 	KDM6A  | a(FIP1L1,PDGFRA)  | a(MDM2,NUP107) 	 0.4726	Model 3101	GDSC
GBM	AZD6482	null	null	33	8	d17q21.2 	KDM6A  | d17q21.2  | a(MYC)  | d10q23.31 	 0.49169	Model 4101	GDSC
GBM	BIRB_0796	null	null	32	5	d3p14.1 	¬NF1  & d(CDKN2A)  & ¬d(CDKN2C,FAF1)  & ¬TGFB-UP 	 0.47902	Model 1401	GDSC
GBM	Bleomycin__50_uM	null	null	35	9	d10p12.1 	TP53  & ¬a7p14.3  & ¬H2O2-UP 	 0.12538	Model 1301	GDSC
GBM	Bortezomib	null	null	14	5	¬d(CDKN2A) 	¬BRAF  & ¬a(CDK4)  & ¬d(CDKN2C,FAF1)  & ¬TGFB-UP 	 0.44176	Model 1401	GDSC
GBM	Bryostatin_1	null	null	30	5	RB1 	PTEN  & ¬d11q14.1  & ¬d10p12.1  & ¬H2O2-UP 	 0.22294	Model 1401	GDSC
GBM	CCT007093	null	null	34	5	JAK-STAT-DOWN 	KDM6A  | d17q21.2  | d8p21.3  | JAK-STAT-DOWN 	 0.4654	Model 4101	GDSC
GBM	CHIR-99021	null	null	31	7	KDM6A 	KDM6A 	 0.53682	Model 1101	GDSC
GBM	CX-5461	null	null	35	17	NF1 	¬d(CDKN2C,FAF1)  & ¬a7q11.23  & ¬TGFB-UP 	 0.24796	Model 1301	GDSC
GBM	GSK269962A	null	null	35	8	a(AKAP9) 	¬RB1  & TP53  & ¬d(FAT1,IRF2)  & ¬d(CDKN2C,FAF1) 	 0.28276	Model 1401	GDSC
GBM	GSK690693	null	null	35	9	d8p21.3 	¬RB1  & ¬d(CDKN2A) 	 0.3697	Model 1201	GDSC
GBM	IOX2	null	null	35	6	VEGF-UP 	d(FAT1,IRF2)  & VEGF-UP   |  d10p12.1  & ¬TGFB-UP 	 0.48259	Model 2201	GDSC
GBM	JQ1	null	null	35	5	d18p11.32 	d12q23.3  | d(TP53)  | d10p12.1 	 0.48588	Model 3101	GDSC
GBM	NSC-87877	null	null	30	5	MAPK_only-UP 	MAPK_only-UP 	 0.58051	Model 1101	GDSC
GBM	Nutlin-3a	null	null	33	8	a(EGFR) 	¬TP53  & ¬d(TP53)  & ¬d(CDKN2C,FAF1)  & ¬d3p14.1 	 0.12153	Model 1401	GDSC
GBM	Olaparib	null	null	34	6	NF1 	NF1  & ¬SACS   |  ¬d(CDKN2A)  & ¬TGFB-UP 	 0.42994	Model 2201	GDSC
GBM	Pazopanib	null	null	29	8	a(AKAP9) 	a(AKAP9) 	 0.436	Model 1101	GDSC
GBM	PLX4720__rescreen	null	null	34	5	d8p21.3 	a(CDK4)  | d8p21.3 	 0.42772	Model 2101	GDSC
GBM	QL-XI-92	null	null	35	16	NF1 	NF1 	 0.35072	Model 1101	GDSC
GBM	RO-3306	null	null	33	8	IL-1-UP 	a(FIP1L1,PDGFRA)  | d8p21.3  | IL-1-UP 	 0.27804	Model 3101	GDSC
GBM	rTRAIL	null	null	34	9	VEGF-UP 	¬EGFR  & ¬NF1  & ¬MAPK_only-UP  & ¬TGFB-UP 	 0.33754	Model 1401	GDSC
GBM	SB_216763	null	null	29	5	d(CDKN2C,FAF1) 	¬RB1  & TP53  & ¬H2O2-UP 	 0.15342	Model 1301	GDSC
GBM	Tamoxifen	null	null	35	5	d8p21.3 	d8p21.3 	 0.5	Model 1201	GDSC
GBM	Temozolomide	null	null	34	6	¬d(CDKN2A) 	¬d(CDKN2A)  & ¬TGFB-UP 	 0.457	Model 1201	GDSC
GBM	TGX221	null	null	14	8	H2O2-UP 	d10q26.3  | a(EGFR)  | H2O2-UP 	 0.23932	Model 3101	GDSC
GBM	Trametinib	null	null	34	7	d18p11.32 	¬PTEN  & ¬TP53 	 0.41265	Model 1201	GDSC
GBM	Tubastatin_A	null	null	35	5	NF1 	¬a(EGFR)  & ¬H2O2-UP  & ¬MAPK_only-UP  & ¬JAK-STAT-DOWN 	 0.37841	Model 1401	GDSC
GBM	Y-39983	null	null	35	17	NF1 	NF1  & ¬JAK-STAT-DOWN 	 0.31718	Model 1201	GDSC
HNSC	17-AAG	null	null	35	6	a(NR2F2,PCSK6) 	a(CCND1,CTTN)  & d(FAT1)  & ¬TNFa-UP 	 0.55208	Model 1301	GDSC
HNSC	_5Z_-7-Oxozeaenol	null	null	38	6	CASP8 	CASP8 	 0.57672	Model 1101	GDSC
HNSC	681640	null	null	26	8	a(ASXL1) 	a(ASXL1) 	 0.40345	Model 1101	GDSC
HNSC	ABT-888	null	null	34	9	a(MCM3) 	¬PIK3CA  & ¬PTEN  & ¬a(FANCG)  & ¬dXq21.33 	 0.3723	Model 1401	GDSC
HNSC	Afatinib	null	null	34	22	a(EGFR) 	¬d(CDKN2A)  & d18q22.1   |  a(EGFR) 	 0.38611	Model 2201	GDSC
HNSC	Afatinib__rescreen	null	null	40	28	a(EGFR) 	SMAD4  | a(EGFR)  | Wnt-DOWN 	 0.25651	Model 3101	GDSC
HNSC	AKT_inhibitor_VIII	null	null	42	9	FBXW7 	¬PBRM1  & ¬d8p23.2  & ¬a22q11.21  & ¬a(CCND1,CTTN) 	 0.325	Model 1401	GDSC
HNSC	AZD6244	null	null	39	12	Wnt-DOWN 	¬HLA-A  & ¬a(CCND1,CTTN)  & ¬dXq21.33  & ¬d(ATP1A1,CSDE1,NRAS) 	 0.33759	Model 1401	GDSC
HNSC	AZD6482	null	null	41	5	a(FANCG) 	PIK3CA  | a(FANCG) 	 0.36573	Model 2101	GDSC
HNSC	Bicalutamide	null	null	37	6	SMAD4 	RASA1  | RHOA  | SMAD4 	 0.39657	Model 3101	GDSC
HNSC	BIRB_0796	null	null	35	8	BPTF 	FBXW7  | a(MYC),a8q24.21 	 0.56494	Model 2101	GDSC
HNSC	Bleomycin__50_uM	null	null	40	20	SMAD4 	SMAD4 	 0.45235	Model 1101	GDSC
HNSC	BMS-708163	null	null	41	10	TNFa-UP 	HLA-A  | a6q11.1  | a(MDM2,NUP107,SRGAP1)  | TNFa-UP 	 0.50354	Model 4101	GDSC
HNSC	Bosutinib	null	null	34	16	SMAD4 	MYH9  | SMAD4  | a(ASXL1)  | PI3K_only-UP 	 0.32682	Model 4101	GDSC
HNSC	CCT007093	null	null	41	10	CDKN2A 	a(ACTB,CARD11,PMS2,RAC1)  | a(NR2F2,PCSK6) 	 0.3524	Model 2101	GDSC
HNSC	Cetuximab	null	null	37	21	Wnt-DOWN 	HLA-A  | PTEN  | Wnt-DOWN 	 0.35054	Model 3101	GDSC
HNSC	CI-1040	null	null	33	9	a(ACTB,CARD11,PMS2,RAC1) 	CDKN2A  & ¬SPTAN1   |  ¬d(CDKN2A)  & Wnt-DOWN 	 0.32849	Model 2201	GDSC
HNSC	CX-5461	null	null	40	17	d(FAT1) 	MAPK_only-UP  | MAPK_PI3K-UP  | Wnt-DOWN 	 0.42742	Model 3101	GDSC
HNSC	Docetaxel	null	null	34	15	SMAD4 	d8p23.2  & dXq21.33 	 0.57362	Model 1201	GDSC
HNSC	EKB-569	null	null	40	7	Wnt-DOWN 	SMAD4  | a(FANCG)  | MAPK_PI3K-UP 	 0.36629	Model 3101	GDSC
HNSC	Epothilone_B	null	null	42	7	d2q21.2 	MYH9  & ¬TNFa-UP   |  d2q21.2  & ¬Wnt-DOWN 	 0.47622	Model 2201	GDSC
HNSC	FTI-277	null	null	42	15	d2q21.2 	¬CASP8  & ¬NSD1  & ¬a(CCND1,CTTN)  & ¬a3q28 	 0.39927	Model 1401	GDSC
HNSC	GDC0941__rescreen	null	null	36	5	TNFa-UP 	SMAD4  | TNFa-UP 	 0.15618	Model 2101	GDSC
HNSC	Gefitinib	null	null	34	26	a(EGFR) 	¬KDM6A  & ¬NSD1  & TP53  & ¬a6q11.1 	 0.24178	Model 1401	GDSC
HNSC	GSK-1904529A	null	null	42	5	FBXW7 	FBXW7  | MAPK_PI3K-UP  | PI3K_only-DOWN 	 0.34601	Model 3101	GDSC
HNSC	GSK-650394	null	null	42	5	SMAD4 	¬PIK3CA  & d8p23.2  & ¬a(CCND1,CTTN) 	 0.17198	Model 1301	GDSC
HNSC	GSK690693	null	null	40	9	Wnt-DOWN 	Wnt-DOWN 	 0.51487	Model 1101	GDSC
HNSC	GW_441756	null	null	34	9	PI3K_only-UP 	FAT1  | FBXW7  | PBRM1  | a(ASXL1) 	 0.3638	Model 4101	GDSC
HNSC	IOX2	null	null	39	10	CDKN2A 	CASP8  | PTEN  | a(MYC),a8q24.21  | VEGF-DOWN 	 0.16364	Model 4101	GDSC
HNSC	JNJ-26854165	null	null	40	7	RHOA 	RHOA 	 0.5	Model 1101	GDSC
HNSC	JNK_Inhibitor_VIII	null	null	35	9	a(ASXL1) 	a(CCND1,CTTN)  & d18q22.1  & ¬PI3K_only-UP 	 0.36966	Model 1301	GDSC
HNSC	JQ1	null	null	38	6	FAT1 	FAT1 	 0.26284	Model 1101	GDSC
HNSC	KIN001-055	null	null	40	9	Wnt-DOWN 	VEGF-DOWN  | Wnt-DOWN 	 0.40573	Model 2101	GDSC
HNSC	Lenalidomide	null	null	34	8	CDKN2A 	TP53  & ¬d(CDKN2A)  & ¬dXq21.33 	 0.44674	Model 1301	GDSC
HNSC	NSC-87877	null	null	42	7	a(ASXL1) 	HLA-A  | KDM6A  | a(MYC),a8q24.21 	 0.52591	Model 3101	GDSC
HNSC	NVP-BEZ235	null	null	35	6	a22q11.21 	KDM6A  | MYH9  | SMAD4  | a22q11.21 	 0.27633	Model 4101	GDSC
HNSC	Obatoclax_Mesylate	null	null	42	9	MAPK_PI3K-UP 	¬a(FANCG)  & Wnt-DOWN   |  ¬d(MED17)  & d2q21.2 	 0.41324	Model 2201	GDSC
HNSC	Olaparib	null	null	39	6	Wnt-DOWN 	¬d8p23.2  & ¬a(CCND1,CTTN)  & ¬d18q22.1 	 0.40607	Model 1301	GDSC
HNSC	PD-0325901	null	null	35	13	PI3K_only-UP 	¬TNFa-UP  & Wnt-DOWN   |  TP53  & PI3K_only-UP 	 0.29195	Model 2201	GDSC
HNSC	PD-173074	null	null	35	5	BPTF 	BPTF  | HLA-B  | KDM6A 	 0.5	Model 3101	GDSC
HNSC	PF-562271	null	null	42	6	FAT1 	KDM6A  | PIK3CA  | RHOA  | VEGF-DOWN 	 0.41726	Model 4101	GDSC
HNSC	PFI-1	null	null	39	6	HLA-A 	TP53  & ¬a(FANCG)  & ¬a(CCND1,CTTN)  & ¬dXq21.33 	 0.3383	Model 1401	GDSC
HNSC	piperlongumine	null	null	39	6	MAPK_PI3K-UP 	a(EGFR)  & d(CDKN2A)   |  CASP8  & ¬d(ATP1A1,CSDE1,NRAS) 	 0.17363	Model 2201	GDSC
HNSC	QL-XI-92	null	null	40	5	MAPK_PI3K-UP 	d(CDKN2A)  & MAPK_PI3K-UP   |  d(FAT1)  & TNFa-UP 	 0.40224	Model 2201	GDSC
HNSC	RDEA119__rescreen	null	null	36	7	CASP8 	APC  | PTEN  | SMAD4  | PI3K_only-UP 	 0.43048	Model 4101	GDSC
HNSC	RO-3306	null	null	35	15	SMAD4 	SMAD4  | PI3K_only-UP 	 0.24848	Model 2101	GDSC
HNSC	rTRAIL	null	null	40	7	FAT1 	FAT1 	 0.55024	Model 1101	GDSC
HNSC	SB590885	null	null	35	7	Wnt-DOWN 	¬a22q11.21  & ¬TNFa-UP  & Wnt-DOWN 	 0.48307	Model 1301	GDSC
HNSC	Shikonin	null	null	41	5	Wnt-DOWN 	Wnt-DOWN 	 0.51144	Model 1101	GDSC
HNSC	SL_0101-1	null	null	35	5	a(EGFR) 	a(CCND1,CTTN)  & d18q22.1 	 0.36902	Model 1201	GDSC
HNSC	Tamoxifen	null	null	39	8	CASP8 	PIK3CA  & ¬d18q22.1   |  ¬PIK3CA  & SMAD4 	 0.40852	Model 2201	GDSC
HNSC	Trametinib	null	null	39	26	Wnt-DOWN 	Wnt-DOWN 	 0.29635	Model 1101	GDSC
HNSC	Vinblastine	null	null	34	5	SMAD4 	MYH9  | SMAD4 	 0.33514	Model 3101	GDSC
HNSC	Vinorelbine	null	null	42	5	EP300 	¬a(EGFR)  & Wnt-DOWN 	 0.19105	Model 1201	GDSC
HNSC	VX-702	null	null	34	9	a(MCM3) 	ATM  | NSD1  | SMAD4  | a(MCM3) 	 0.516	Model 4101	GDSC
HNSC	XAV_939	null	null	40	12	PBRM1 	PBRM1  | a(ACTB,CARD11,PMS2,RAC1) 	 0.32718	Model 2101	GDSC
HNSC	Y-39983	null	null	40	6	¬TP53 	¬TP53  | MAPK_PI3K-UP 	 0.23313	Model 4101	GDSC
KIRC	ABT-263	null	null	23	5	PI3K_only-DOWN 	¬SOX9  & ¬VHL  & d14q24.3 	 0.37272	Model 1301	GDSC
KIRC	Afatinib	null	null	23	8	NF2 	NF2 	 0.26438	Model 1101	GDSC
KIRC	Afatinib__rescreen	null	null	30	11	NF2 	¬BAP1  & ¬TP53  & ¬VHL 	 0.14023	Model 1301	GDSC
KIRC	AMG-706	null	null	22	5	PBRM1 	PBRM1  | TNFa-UP 	 0.35707	Model 2101	GDSC
KIRC	AZD6482	null	null	31	15	TGFB-DOWN 	¬TP53  & ¬MAPK_only-UP  & ¬TNFa-UP 	 0.47387	Model 1301	GDSC
KIRC	BIRB_0796	null	null	23	4	PBRM1 	¬SOX9  & ¬TP53  & d3p14.1  & ¬d1p31.1 	 0.38369	Model 1401	GDSC
KIRC	Bleomycin__50_uM	null	null	31	8	SMARCA4 	¬VHL  & d(CDKN2A)  & ¬d(FAT1,IRF2)  & ¬TNFa-UP 	 0.15162	Model 1401	GDSC
KIRC	CCT007093	null	null	31	6	MGA 	KDM6A  | MGA  | PTEN 	 0.42271	Model 3101	GDSC
KIRC	Cetuximab	null	null	30	12	KDM6A 	¬BAP1  & ¬TP53  & ¬VHL  & ¬d15q15.1 	 0.29273	Model 1401	GDSC
KIRC	CH5424802	null	null	30	5	d4q21.22 	MGA  | d3q11.1 	 0.43067	Model 2101	GDSC
KIRC	CHIR-99021	null	null	30	9	KDM6A 	¬TP53  & ¬VHL  & ¬d(FAT1,IRF2)  & ¬TNFa-UP 	 0.22335	Model 1401	GDSC
KIRC	Cisplatin	null	null	23	6	PI3K_only-DOWN 	PI3K_only-DOWN 	 0.5	Model 1101	GDSC
KIRC	CX-5461	null	null	29	8	d1p31.1 	PTEN  & TP53   |  ¬TP53  & d3p14.1 	 0.51822	Model 2201	GDSC
KIRC	Dabrafenib	null	null	28	8	NF2 	NF2  | TGFB-DOWN 	 0.10274	Model 2101	GDSC
KIRC	Gefitinib	null	null	23	7	NF2 	NF2 	 0.23581	Model 1101	GDSC
KIRC	Gemcitabine	null	null	22	5	NF2 	¬BAP1  & NF2  & d(CDKN2A)  & ¬d2q22.1 	 0.48489	Model 1401	GDSC
KIRC	GSK429286A	null	null	30	6	d14q24.3 	¬d(SOX17)  & d14q24.3  & ¬JAK-STAT-DOWN 	 0.13973	Model 1301	GDSC
KIRC	GSK690693	null	null	30	9	PTEN 	PTEN  | d15q15.1  | TGFB-DOWN 	 0.23661	Model 3101	GDSC
KIRC	GW_441756	null	null	23	7	PBRM1 	PBRM1 	 0.5694	Model 1101	GDSC
KIRC	JNJ-26854165	null	null	29	6	PTEN 	¬MGA  & VHL  & ¬MAPK_only-UP 	 0.16084	Model 1301	GDSC
KIRC	JNK_Inhibitor_VIII	null	null	22	5	PBRM1 	PBRM1  & VHL 	 0.28106	Model 1201	GDSC
KIRC	JW-7-24-1	null	null	30	7	d4q21.22 	¬TP53  & d3p14.1  & ¬d2q22.1 	 0.39044	Model 1301	GDSC
KIRC	LFM-A13	null	null	23	5	SETD2 	FBXW7   |  ¬MGA  & SETD2 	 0.49698	Model 2201	GDSC
KIRC	LY317615	null	null	30	6	MAPK_only-UP 	¬d6q27  & d(FAT1,IRF2)   |  d14q24.3  & MAPK_only-UP 	 0.53895	Model 2201	GDSC
KIRC	MP470	null	null	30	5	d(FAT1,IRF2) 	¬TP53  & d(FAT1,IRF2) 	 0.30879	Model 1201	GDSC
KIRC	Nutlin-3a	null	null	23	9	BAP1 	¬TP53  & ¬d6q27  & ¬TGFB-DOWN 	 0.19764	Model 1301	GDSC
KIRC	NVP-BEZ235	null	null	23	5	d4q21.22 	d4q21.22 	 0.50686	Model 1101	GDSC
KIRC	QL-XI-92	null	null	30	10	d14q24.3 	d3q11.1  & d(FAT1,IRF2)   |  ¬d6q27  & d14q24.3 	 0.39629	Model 2201	GDSC
KIRC	rTRAIL	null	null	30	5	EZH2 	EZH2 	 0.50696	Model 1101	GDSC
KIRC	STF-62247	null	null	29	7	d3q11.1 	¬MGA  & ¬d6q27  & d3p14.1  & ¬d2q22.1 	 0.14796	Model 1401	GDSC
KIRC	Temsirolimus	null	null	23	7	d(SOX17) 	¬BAP1  & ¬NF2  & ¬d1p31.1  & ¬MAPK_only-UP 	 0.43086	Model 1401	GDSC
KIRC	TGX221	null	null	10	5	d1p31.1 	¬d8p23.1  & ¬MAPK_only-UP  & ¬TNFa-UP  & ¬VEGF-UP 	 0.32264	Model 1401	GDSC
KIRC	Trametinib	null	null	30	9	NF2 	NF2  | TGFB-DOWN 	 0.36125	Model 2101	GDSC
KIRC	XAV_939	null	null	30	7	d2q22.1 	d2q22.1 	 0.5	Model 1101	GDSC
KIRC	Y-39983	null	null	30	13	d14q24.3 	¬NFE2L2  & ¬d(SOX17)  & d14q24.3  & ¬d2q22.1 	 0.37977	Model 1401	GDSC
LAML	5-Fluorouracil	null	null	25	13	TET2 	¬NOTCH1  & ¬TP53 	 0.14078	Model 1201	GDSC
LAML	_5Z_-7-Oxozeaenol	null	null	26	10	H2O2-DOWN 	NPM1  | RUNX1-RUNX1T1  | U2AF1  | H2O2-DOWN 	 0.28138	Model 4101	GDSC
LAML	A-770041	null	null	26	7	FBXW7 	¬ASXL1  & ¬NRAS  & ¬IL-1-UP  & JAK-STAT-UP 	 0.2563	Model 1401	GDSC
LAML	ABT-263	null	null	23	18	¬JAK-STAT-UP 	d9p13.1  | ¬JAK-STAT-UP  | H2O2-DOWN 	 0.42186	Model 3101	GDSC
LAML	ABT-869	null	null	26	13	U2AF1 	¬NRAS  & ¬IL-1-UP  & ¬TLR-UP  & ¬IL-1-DOWN 	 0.26651	Model 1401	GDSC
LAML	ABT-888	null	null	24	5	d9p13.1 	U2AF1  | d9p13.1  | VEGF-UP 	 0.54912	Model 3101	GDSC
LAML	AC220	null	null	26	17	U2AF1 	¬KRAS  & ¬NRAS 	 0.034986	Model 1301	GDSC
LAML	AICAR	null	null	24	11	U2AF1 	¬KRAS  & ¬TP53  & ¬TLR-UP 	 0.36636	Model 1301	GDSC
LAML	AP-24534	null	null	26	9	U2AF1 	FLT3  | MAP3K1  | RUNX1-RUNX1T1  | U2AF1 	 0.38246	Model 4101	GDSC
LAML	AR-42	null	null	25	10	TLR-UP 	¬KRAS  & ¬NOTCH1  & ¬NRAS  & ¬d7p12.1 	 0.22627	Model 1401	GDSC
LAML	AS605240	null	null	26	15	TET2 	KRAS  | PML-RARA  | TET2 	 0.40127	Model 3101	GDSC
LAML	AT-7519	null	null	26	8	U2AF1 	¬NRAS  & TP53  & JAK-STAT-UP 	 0.40162	Model 1301	GDSC
LAML	ATRA	null	null	24	9	ASXL1 	NRAS  & ¬TP53   |  ¬RUNX1-RUNX1T1  & ASXL1 	 0.16794	Model 2201	GDSC
LAML	AV-951	null	null	26	12	RUNX1-RUNX1T1 	¬KRAS  & ¬NRAS  & ¬IL-1-UP  & ¬TLR-UP 	 0.11824	Model 1401	GDSC
LAML	AZ628	null	null	26	14	TET2 	¬TP53  & ¬TLR-UP 	 0.38809	Model 1201	GDSC
LAML	AZD6244	null	null	26	6	NPM1 	¬EP300  & ¬TP53  & JAK-STAT-UP 	 0.52353	Model 1301	GDSC
LAML	AZD7762	null	null	24	8	U2AF1 	U2AF1 	 0.40156	Model 1101	GDSC
LAML	AZD8055	null	null	23	5	ASXL1 	¬NF1  & ASXL1 	 0.39126	Model 1201	GDSC
LAML	BAY_61-3606	null	null	25	8	FLT3 	¬ASXL1  & ¬NOTCH1  & ¬NRAS  & ¬TP53 	 0.27554	Model 1401	GDSC
LAML	Bexarotene	null	null	25	5	TET2 	CDKN2A  | TET2  | IL-1-UP 	 0.04081	Model 3101	GDSC
LAML	Bicalutamide	null	null	25	5	SACS 	¬ASXL1  & ¬NRAS  & JAK-STAT-UP  & ¬H2O2-DOWN 	 0.27351	Model 1401	GDSC
LAML	BIX02189	null	null	25	16	PTPN11 	¬CDKN2A  & ¬TP53 	 0.14999	Model 1201	GDSC
LAML	BMS-345541	null	null	26	16	ASXL1 	ASXL1  | NOTCH1  | PML-RARA  | TET2 	 0.30493	Model 4101	GDSC
LAML	BMS-509744	null	null	26	5	H2O2-DOWN 	FLT3  | NOTCH1  | TET2  | IL-1-DOWN 	 0.31112	Model 4101	GDSC
LAML	BMS-536924	null	null	26	6	ASXL1 	¬NRAS  & ¬JAK-STAT-UP  & ¬TLR-UP 	 0.39489	Model 1301	GDSC
LAML	BMS-708163	null	null	26	13	SACS 	¬CREBBP  & ¬KRAS  & JAK-STAT-UP 	 0.22479	Model 1301	GDSC
LAML	BMS-754807	null	null	24	5	PML-RARA 	PML-RARA 	 0.5	Model 1101	GDSC
LAML	Bryostatin_1	null	null	25	5	TET2 	¬ASXL1  & ¬NRAS  & ¬IL-1-UP  & JAK-STAT-UP 	 0.20673	Model 1401	GDSC
LAML	BX-795	null	null	23	4	U2AF1 	FLT3  | U2AF1  | VEGF-UP 	 0.22232	Model 3101	GDSC
LAML	BX-912	null	null	26	14	ASXL1 	¬NRAS  & ¬JAK-STAT-UP  & ¬TNFa-UP 	 0.37755	Model 1301	GDSC
LAML	CAL-101	null	null	26	16	ASXL1 	¬CDKN2A  & ¬DNMT3A  & ¬TP53 	 0.32081	Model 1301	GDSC
LAML	CAY10603	null	null	25	9	PML-RARA 	¬ASXL1  & ¬NOTCH1  & ¬NRAS  & ¬H2O2-DOWN 	 0.17107	Model 1401	GDSC
LAML	CCT018159	null	null	26	6	STAG2 	¬CREBBP  & ¬KRAS  & ¬NRAS  & TP53 	 0.42492	Model 1401	GDSC
LAML	CEP-701	null	null	24	9	FLT3 	FLT3  & H2O2-DOWN   |  ¬NRAS  & TP53 	 0.36011	Model 2201	GDSC
LAML	CH5424802	null	null	26	15	FLT3 	¬MAP3K1  & ¬KRAS  & ¬NRAS  & ¬TLR-UP 	 0.53491	Model 1401	GDSC
LAML	CHIR-99021	null	null	26	5	SACS 	RUNX1-RUNX1T1  | SACS  | VEGF-UP 	 0.39835	Model 4101	GDSC
LAML	CI-1040	null	null	24	9	KRAS 	¬d6p21.33  & ¬EP300  & ¬IL-1-UP  & JAK-STAT-UP 	 0.27925	Model 1401	GDSC
LAML	CP466722	null	null	26	14	ASXL1 	¬CREBBP  & ¬NRAS  & ¬TET2  & ¬d9p13.1 	 0.14021	Model 1401	GDSC
LAML	CP724714	null	null	26	7	d6p21.33 	¬ASXL1  & ¬EP300  & JAK-STAT-UP  & ¬H2O2-DOWN 	 0.43632	Model 1401	GDSC
LAML	Crizotinib	null	null	26	6	FBXW7 	¬NRAS  & ¬TP53  & ¬TLR-UP 	 0.37574	Model 1301	GDSC
LAML	Cyclopamine	null	null	26	6	NOTCH1 	¬ASXL1  & ¬NRAS  & JAK-STAT-UP 	 0.023908	Model 1301	GDSC
LAML	Dabrafenib	null	null	26	10	RUNX1-RUNX1T1 	FLT3  | PTPN11  | RUNX1-RUNX1T1  | U2AF1 	 0.48197	Model 4101	GDSC
LAML	EKB-569	null	null	26	13	d6p21.33 	¬ASXL1  & ¬CREBBP  & ¬NRAS 	 0.27517	Model 1301	GDSC
LAML	EX-527	null	null	25	8	TET2 	¬NRAS  & JAK-STAT-UP  & ¬H2O2-DOWN  & ¬IL-1-DOWN 	 0.14184	Model 1401	GDSC
LAML	FMK	null	null	26	15	NOTCH1 	¬NRAS  & JAK-STAT-UP 	 0.15741	Model 1201	GDSC
LAML	FR-180204	null	null	25	15	TET2 	¬FBXW7  & ¬NRAS  & ¬d9p13.1  & ¬TLR-UP 	 0.17739	Model 1401	GDSC
LAML	FTI-277	null	null	26	5	RUNX1-RUNX1T1 	RUNX1-RUNX1T1 	 0.51844	Model 1101	GDSC
LAML	GDC0941	null	null	23	6	CDKN2A 	CDKN2A 	 0.5	Model 1101	GDSC
LAML	Genentech_Cpd_10	null	null	26	14	TLR-UP 	¬NF1  & ¬KRAS  & ¬NRAS 	 0.17031	Model 1301	GDSC
LAML	GSK1070916	null	null	25	18	¬TP53 	¬TP53   |  ¬NRAS  & JAK-STAT-UP 	 0.056544	Model 2201	GDSC
LAML	GSK2126458	null	null	26	15	ASXL1 	¬NRAS  & ¬JAK-STAT-UP 	 0.31162	Model 1201	GDSC
LAML	GSK269962A	null	null	26	5	CREBBP 	RUNX1-RUNX1T1  | CREBBP 	 0.30488	Model 2101	GDSC
LAML	GSK429286A	null	null	26	16	PTPN11 	¬TP53  & ¬U2AF1  & ¬MAPK_only-DOWN 	 0.21505	Model 1301	GDSC
LAML	GSK-650394	null	null	24	6	FLT3 	¬NOTCH1  & ¬NRAS  & ¬TP53  & ¬TLR-UP 	 0.19567	Model 1401	GDSC
LAML	GSK690693	null	null	26	18	TLR-UP 	¬NRAS  & ¬d9p13.1  & ¬JAK-STAT-UP 	 0.39484	Model 1401	GDSC
LAML	GW-2580	null	null	26	10	PTPN11 	¬TP53  & ¬TLR-UP  & ¬H2O2-DOWN 	 0.23593	Model 1301	GDSC
LAML	HG-6-64-1	null	null	26	6	U2AF1 	FLT3  | MAP3K1  | RUNX1-RUNX1T1  | U2AF1 	 0.30789	Model 4101	GDSC
LAML	I-BET_151	null	null	25	20	¬TP53 	¬EP300  & ¬NRAS 	 0.19528	Model 1201	GDSC
LAML	JQ12	null	null	26	7	IL-1-UP 	IL-1-UP 	 0.5	Model 1101	GDSC
LAML	JQ1	null	null	26	11	TLR-UP 	CREBBP  | IL-1-UP  | TLR-UP  | H2O2-DOWN 	 0.49299	Model 4101	GDSC
LAML	JW-7-24-1	null	null	26	16	RUNX1-RUNX1T1 	¬NRAS  & ¬U2AF1  & ¬d9p13.1  & ¬IL-1-DOWN 	 0.24224	Model 1401	GDSC
LAML	KIN001-055	null	null	25	6	d6p21.33 	TP53  & JAK-STAT-UP  & ¬H2O2-DOWN  & ¬IL-1-DOWN 	 0.32655	Model 1401	GDSC
LAML	KIN001-102	null	null	26	17	ASXL1 	ASXL1  & ¬d9p13.1   |  ¬TP53  & ¬JAK-STAT-UP 	 0.2885	Model 2201	GDSC
LAML	KIN001-135	null	null	26	5	H2O2-DOWN 	¬NRAS  & ¬TP53  & JAK-STAT-UP 	 0.053435	Model 1301	GDSC
LAML	KIN001-236	null	null	25	16	TNFa-UP 	¬ASXL1  & ¬NRAS 	 0.051102	Model 1201	GDSC
LAML	KIN001-244	null	null	25	12	TET2 	¬MAP3K1  & ¬TP53  & JAK-STAT-UP 	 0.2603	Model 1301	GDSC
LAML	KIN001-270	null	null	25	10	TET2 	¬KRAS  & ¬NRAS  & ¬U2AF1  & ¬TLR-UP 	 0.38799	Model 1401	GDSC
LAML	KU-55933	null	null	23	4	VEGF-UP 	d9p13.1  | VEGF-UP  | H2O2-DOWN 	 0.4772	Model 3101	GDSC
LAML	LAQ824	null	null	25	8	IL-1-UP 	¬KRAS  & ¬NRAS  & ¬SACS  & ¬TLR-UP 	 0.36483	Model 1401	GDSC
LAML	Lenalidomide	null	null	24	12	STAG2 	¬TP53  & JAK-STAT-UP   |  STAG2  & ¬KRAS 	 0.42962	Model 2201	GDSC
LAML	LY317615	null	null	26	8	FBXW7 	SACS  & ¬IL-1-DOWN 	 0.50545	Model 1201	GDSC
LAML	Masitinib	null	null	25	8	RUNX1-RUNX1T1 	¬NRAS  & ¬JAK-STAT-UP 	 0.18754	Model 1201	GDSC
LAML	Methotrexate	null	null	24	13	U2AF1 	JAK-STAT-UP  & ¬IL-1-DOWN 	 0.18024	Model 1201	GDSC
LAML	Midostaurin	null	null	26	5	U2AF1 	FLT3  | PTPN11  | RUNX1-RUNX1T1  | U2AF1 	 0.30717	Model 4101	GDSC
LAML	MP470	null	null	26	6	RUNX1-RUNX1T1 	RUNX1-RUNX1T1 	 0.52232	Model 1101	GDSC
LAML	MPS-1-IN-1	null	null	25	6	TET2 	TET2  & ¬H2O2-DOWN   |  CREBBP  & NOTCH1 	 0.28454	Model 2201	GDSC
LAML	NG-25	null	null	25	11	U2AF1 	¬CREBBP  & ¬KRAS  & ¬NRAS  & ¬MAPK_only-DOWN 	 0.10205	Model 1401	GDSC
LAML	Nilotinib	null	null	24	9	RUNX1-RUNX1T1 	RUNX1-RUNX1T1 	 0.5	Model 1101	GDSC
LAML	NPK76-II-72-1	null	null	25	12	PML-RARA 	¬ASXL1  & ¬NRAS  & ¬SACS  & ¬IL-1-UP 	 0.33712	Model 1401	GDSC
LAML	Nutlin-3a	null	null	23	11	¬TP53 	¬TP53 	 0.030576	Model 1101	GDSC
LAML	NVP-BHG712	null	null	25	14	¬TP53 	¬TP53 	 0.19597	Model 1201	GDSC
LAML	NVP-TAE684	null	null	26	7	PTPN11 	FLT3  | PTPN11  | TET2 	 0.45384	Model 3101	GDSC
LAML	Olaparib	null	null	24	5	U2AF1 	U2AF1 	 0.5	Model 1101	GDSC
LAML	OSI-027	null	null	26	10	¬JAK-STAT-UP 	¬NRAS  & ¬JAK-STAT-UP 	 0.19806	Model 1201	GDSC
LAML	OSI-906	null	null	24	7	KRAS 	KRAS 	 0.51936	Model 1101	GDSC
LAML	OSI-930	null	null	26	16	d7p12.1 	¬CREBBP  & ¬KRAS  & ¬NRAS  & ¬TLR-UP 	 0.23964	Model 1401	GDSC
LAML	PAC-1	null	null	25	6	TET2 	¬ASXL1  & ¬NRAS  & JAK-STAT-UP  & ¬H2O2-DOWN 	 0.38637	Model 1401	GDSC
LAML	PD-0325901	null	null	23	8	NRAS 	¬SACS  & ¬U2AF1  & ¬IL-1-UP  & JAK-STAT-UP 	 0.34759	Model 1401	GDSC
LAML	PD-173074	null	null	23	5	VEGF-UP 	TP53  & ¬JAK-STAT-UP   |  ¬CREBBP  & EP300 	 0.47022	Model 2201	GDSC
LAML	PF-562271	null	null	26	5	FLT3 	¬FBXW7  & ¬KRAS  & ¬NRAS  & JAK-STAT-UP 	 0.088849	Model 1401	GDSC
LAML	PFI-1	null	null	26	7	RUNX1-RUNX1T1 	¬NRAS  & ¬SACS  & TP53  & ¬IL-1-DOWN 	 0.44872	Model 1401	GDSC
LAML	PHA-665752	null	null	26	5	PTPN11 	¬CREBBP  & ¬NRAS  & ¬TP53  & ¬TLR-UP 	 0.21457	Model 1401	GDSC
LAML	PHA-793887	null	null	26	13	PML-RARA 	FLT3  | PML-RARA  | TET2  | U2AF1 	 0.43191	Model 4101	GDSC
LAML	Phenformin	null	null	25	8	CREBBP 	PTPN11  | CREBBP  | SACS  | IL-1-UP 	 0.39019	Model 4101	GDSC
LAML	PI-103	null	null	26	11	¬JAK-STAT-UP 	¬NRAS  & ¬JAK-STAT-UP 	 0.29938	Model 1201	GDSC
LAML	PIK-93	null	null	25	16	¬TP53 	ASXL1  | ¬TP53 	 0.095277	Model 2101	GDSC
LAML	PXD101_Belinostat	null	null	25	6	TET2 	TET2 	 0.48851	Model 1201	GDSC
LAML	QL-X-138	null	null	22	6	TNFa-UP 	¬NRAS  & ¬JAK-STAT-UP 	 0.39591	Model 1201	GDSC
LAML	QL-XI-92	null	null	26	20	¬TP53 	RUNX1-RUNX1T1  | PML-RARA  | ¬TP53 	 0.17604	Model 3101	GDSC
LAML	RDEA119	null	null	23	7	NRAS 	¬d6p21.33  & ¬SACS  & ¬IL-1-UP  & JAK-STAT-UP 	 0.46013	Model 1401	GDSC
LAML	RDEA119__rescreen	null	null	26	5	d9p13.1 	¬NOTCH1  & ¬NRAS  & ¬IL-1-UP  & JAK-STAT-UP 	 0.44796	Model 1401	GDSC
LAML	rTRAIL	null	null	26	9	KRAS 	¬JAK-STAT-UP  & H2O2-DOWN   |  KRAS  & ¬NRAS 	 0.3264	Model 2201	GDSC
LAML	Ruxolitinib	null	null	26	15	SACS 	¬KRAS  & ¬NRAS  & ¬U2AF1  & ¬TLR-UP 	 0.14916	Model 1401	GDSC
LAML	SB590885	null	null	23	6	PML-RARA 	PML-RARA 	 0.5	Model 1101	GDSC
LAML	SGC0946	null	null	26	5	U2AF1 	¬PTPN11  & ¬NRAS  & ¬JAK-STAT-UP  & ¬TLR-UP 	 0.35382	Model 1401	GDSC
LAML	SNX-2112	null	null	25	11	U2AF1 	¬ASXL1  & ¬NRAS  & ¬SACS 	 0.19083	Model 1301	GDSC
LAML	Sorafenib	null	null	26	7	U2AF1 	FLT3  | U2AF1 	 0.28521	Model 2101	GDSC
LAML	STF-62247	null	null	25	17	H2O2-DOWN 	¬CDKN2A  & ¬d9p13.1  & JAK-STAT-UP 	 0.2934	Model 1301	GDSC
LAML	Sunitinib	null	null	26	7	U2AF1 	¬NOTCH1  & ¬NRAS  & ¬TP53  & ¬TLR-UP 	 0.38389	Model 1401	GDSC
LAML	TAK-715	null	null	26	10	d6p21.33 	MAP3K1  | d6p21.33 	 0.53954	Model 2101	GDSC
LAML	Tamoxifen	null	null	26	7	d9p13.1 	¬NRAS  & JAK-STAT-UP  & ¬H2O2-DOWN 	 0.19308	Model 1301	GDSC
LAML	Temozolomide	null	null	26	10	U2AF1 	¬PTPN11  & ¬ASXL1  & ¬NRAS  & ¬H2O2-DOWN 	 0.31439	Model 1401	GDSC
LAML	TG101348	null	null	26	20	¬NRAS 	¬NRAS 	 0.0015423	Model 1101	GDSC
LAML	THZ-2-102-1	null	null	25	10	U2AF1 	¬NRAS  & ¬d9p13.1  & JAK-STAT-UP 	 0.23595	Model 1301	GDSC
LAML	THZ-2-49	null	null	25	5	TET2 	U2AF1  & ¬JAK-STAT-UP   |  TET2  & JAK-STAT-UP 	 0.5279	Model 2201	GDSC
LAML	Tipifarnib	null	null	24	7	TLR-UP 	¬FLT3  & ¬ASXL1  & ¬NRAS  & ¬SACS 	 0.42636	Model 1401	GDSC
LAML	TL-1-85	null	null	25	10	U2AF1 	¬CREBBP  & ¬KRAS  & ¬NRAS  & ¬MAPK_only-DOWN 	 0.11672	Model 1401	GDSC
LAML	TL-2-105	null	null	26	14	PTPN11 	¬CDKN2A  & ¬TP53  & ¬TLR-UP 	 0.19702	Model 1301	GDSC
LAML	TPCA-1	null	null	25	15	IL-1-UP 	¬NOTCH1  & ¬NRAS  & ¬MAPK_only-DOWN 	 0.0097261	Model 1401	GDSC
LAML	Trametinib	null	null	23	8	H2O2-DOWN 	NPM1  | H2O2-DOWN 	 0.47917	Model 2101	GDSC
LAML	UNC1215	null	null	26	10	RUNX1-RUNX1T1 	RUNX1-RUNX1T1  | SACS 	 0.47342	Model 2101	GDSC
LAML	VNLG124	null	null	24	17	TET2 	KRAS  | TET2 	 0.32969	Model 2101	GDSC
LAML	Vorinostat	null	null	24	7	RUNX1-RUNX1T1 	RUNX1-RUNX1T1 	 0.5	Model 1101	GDSC
LAML	VX-11e	null	null	25	10	TET2 	¬SACS  & ¬TP53  & JAK-STAT-UP 	 0.36667	Model 1301	GDSC
LAML	VX-680	null	null	25	11	TLR-UP 	¬NPM1  & ¬TP53 	 0.18833	Model 1201	GDSC
LAML	VX-702	null	null	24	10	STAG2 	¬NRAS  & TP53  & ¬IL-1-DOWN 	 0.45404	Model 1301	GDSC
LAML	WZ3105	null	null	26	9	FLT3 	FLT3  | PML-RARA  | TET2  | U2AF1 	 0.35731	Model 4101	GDSC
LAML	XL-184	null	null	25	8	U2AF1 	FLT3  | PTPN11  | TET2  | U2AF1 	 0.31607	Model 4101	GDSC
LAML	XL-880	null	null	25	6	U2AF1 	¬NOTCH1  & ¬NRAS  & ¬TP53  & ¬TLR-UP 	 0.35272	Model 1401	GDSC
LAML	XMD13-2	null	null	26	8	PML-RARA 	PTPN11  | NOTCH1  | PML-RARA  | TLR-UP 	 0.44709	Model 4101	GDSC
LAML	XMD14-99	null	null	26	19	¬TP53 	d6p21.33  & NRAS   |  ¬KRAS  & ¬NRAS 	 0.14714	Model 2201	GDSC
LAML	XMD15-27	null	null	26	15	TLR-UP 	¬ASXL1  & ¬CREBBP  & ¬NRAS 	 0.037572	Model 1301	GDSC
LAML	Y-39983	null	null	25	20	¬NRAS 	CDKN2A  | ¬NRAS 	 0.023136	Model 2101	GDSC
LAML	YM201636	null	null	25	7	TET2 	¬TP53  & ¬JAK-STAT-UP 	 0.099833	Model 1201	GDSC
LAML	Zibotentan_ZD4054	null	null	25	12	CREBBP 	¬TP53  & JAK-STAT-UP   |  SACS  & ¬U2AF1 	 0.31353	Model 2201	GDSC
LAML	ZM-447439	null	null	23	7	FLT3 	FLT3  | STAG2  | ASXL1  | EP300 	 0.28916	Model 4101	GDSC
LAML	ZSTK474	null	null	26	14	ASXL1 	¬CDKN2A  & ¬DNMT3A  & ¬TP53 	 0.32439	Model 1301	GDSC
LGG	A-770041	null	null	11	6	a(KRAS) 	¬EP300  & ¬d(RPL22)  & ¬PI3K_only-DOWN 	 0.37454	Model 1301	GDSC
LGG	Bleomycin__50_uM	null	null	17	7	a(EGFR) 	¬TP53  & H2O2-UP   |  ¬PTEN  & a(EGFR) 	 0.29229	Model 2201	GDSC
LGG	Docetaxel	null	null	15	5	a(EGFR) 	¬PTEN  & H2O2-UP   |  a(EGFR)  & ¬TNFa-UP 	 0.26225	Model 2201	GDSC
LGG	GSK690693	null	null	17	6	SMARCA4 	¬EP300  & ¬d(RPL22)  & ¬a(FGFR1,WHSC1L1)  & ¬d(CUL2) 	 0.49308	Model 1401	GDSC
LGG	Nutlin-3a	null	null	15	5	¬TP53 	¬SMARCA4  & ¬TP53 	 0.052348	Model 1201	GDSC
LGG	QL-XI-92	null	null	17	10	IL-1-UP 	EP300  | SETD2  | IL-1-UP  | PI3K_only-DOWN 	 0.28445	Model 4101	GDSC
LGG	RO-3306	null	null	15	5	a(EGFR) 	¬EP300  & ¬d(RPL22)  & ¬TGFB-UP 	 0.13528	Model 1301	GDSC
LGG	SB_216763	null	null	14	6	H2O2-UP 	H2O2-UP  | PI3K_only-DOWN 	 0.029282	Model 2101	GDSC
LGG	Tubastatin_A	null	null	17	5	a(EGFR) 	¬PTEN  & a(EGFR) 	 0.20132	Model 1201	GDSC
LGG	Y-39983	null	null	17	5	TLR-DOWN 	¬d(CUL2)  & TGFB-UP  & ¬TNFa-UP  & ¬PI3K_only-DOWN 	 0.26507	Model 1401	GDSC
LIHC	CX-5461	null	null	17	7	¬TP53 	¬PHLPP1  & ¬d(CDKN2A)  & ¬IL-1-UP  & ¬MAPK_only-DOWN 	 0.35542	Model 1401	GDSC
LIHC	FH535	null	null	17	5	FAM123B 	ACVR2A  | PHLPP1  | RB1  | CTNNB1 	 0.5	Model 4101	GDSC
LIHC	GSK-1904529A	null	null	17	5	d(RB1) 	ACVR2A  | CREBBP  | CTNNB1  | d(RB1) 	 0.38961	Model 4101	GDSC
LIHC	JQ1	null	null	16	7	IL-1-UP 	¬TP53  & ¬CREBBP   |  ¬RB1  & IL-1-UP 	 0.54794	Model 2201	GDSC
LIHC	NSC-207895	null	null	17	5	MAPK_PI3K-UP 	MAPK_PI3K-UP 	 0.5	Model 1101	GDSC
LIHC	Pazopanib	null	null	17	7	¬TP53 	ACVR2A  | CREBBP  | CTNNB1  | d(RB1) 	 0.42007	Model 4101	GDSC
LIHC	Tipifarnib	null	null	17	5	¬TP53 	CTNNB1  | SMARCA4  | d(RB1) 	 0.33807	Model 3101	GDSC
LIHC	Trametinib	null	null	16	7	¬TP53 	¬TP53  & ¬CTNNB1   |  FAM123B  & ¬CTNNB1 	 0.22387	Model 2201	GDSC
LIHC	Y-39983	null	null	17	9	ARID1A 	TP53  & ¬d(CDKN2A)  & ¬FAM123B  & ¬MAPK_PI3K-UP 	 0.44821	Model 1401	GDSC
LUAD	17-AAG	null	null	53	5	CUL2 	CUL2  | a(ARFGAP1) 	 0.46261	Model 2101	GDSC
LUAD	A-770041	null	null	13	5	EGFR 	¬SMARCA4  & a(CCND1)   |  a(MET)  & ¬d(FAT1,IRF2) 	 0.38428	Model 2201	GDSC
LUAD	Afatinib	null	null	51	16	EGFR 	EGFR 	 0.20778	Model 1101	GDSC
LUAD	Afatinib__rescreen	null	null	57	17	EGFR 	EGFR  | d22q13.31 	 0.18778	Model 2101	GDSC
LUAD	AKT_inhibitor_VIII	null	null	58	10	a(TERT) 	d(CDKN2A)  & a(TERT)   |  ¬SMARCA4  & SVEP1 	 0.46987	Model 2201	GDSC
LUAD	AMG-706	null	null	53	8	TGFB-DOWN 	¬TP53  & ¬MAPK_only-UP  & ¬JAK-STAT-DOWN 	 0.41633	Model 1301	GDSC
LUAD	AS601245	null	null	57	8	PI3K_only-UP 	KEAP1  | PI3K_only-UP  | TGFB-DOWN 	 0.39907	Model 3101	GDSC
LUAD	AS605240	null	null	60	6	d17p11.2 	d17p11.2  | a(MECOM) 	 0.23892	Model 2101	GDSC
LUAD	AUY922	null	null	58	5	a(TERT) 	¬STK11  & a(ARFGAP1)   |  U2AF1  & MAPK_only-UP 	 0.22683	Model 2201	GDSC
LUAD	AZD6244	null	null	61	6	¬TP53 	¬TP53 	 0.33328	Model 1101	GDSC
LUAD	Bicalutamide	null	null	58	5	PI3K_only-UP 	SOX9  | a(ARFGAP1)  | PI3K_only-UP 	 0.36596	Model 3101	GDSC
LUAD	BIRB_0796	null	null	53	6	CDKN2A 	CDKN2A  | MAP4K3  | NTRK2  | d17p11.2 	 0.38741	Model 4101	GDSC
LUAD	Bleomycin__50_uM	null	null	61	10	a(CCND1) 	KRAS  & ¬RBM10  & ¬d19p12  & ¬a12q12 	 0.41683	Model 1401	GDSC
LUAD	Bleomycin	null	null	58	6	a(KRAS) 	d22q11.1  & ¬d22q13.31   |  a(KRAS)  & ¬a12q12 	 0.25487	Model 2201	GDSC
LUAD	BMN-673	null	null	59	7	PTEN 	PTEN 	 0.50909	Model 1201	GDSC
LUAD	BMS-345541	null	null	60	5	d(SMARCA4) 	d(SMARCA4) 	 0.43334	Model 1101	GDSC
LUAD	BMS-536924	null	null	60	5	U2AF1 	U2AF1  | a(FOXA2) 	 0.29182	Model 2101	GDSC
LUAD	BMS-708163	null	null	57	11	d22q11.1 	d22q11.1  & ¬aXq28   |  KRAS  & a(MYC) 	 0.41887	Model 2201	GDSC
LUAD	BMS-754807	null	null	58	11	KEAP1 	KRAS  & ¬RBM10  & ¬SMARCA4 	 0.35835	Model 1301	GDSC
LUAD	Bryostatin_1	null	null	58	8	a(TERT) 	¬NRAS  & ¬a(ASXL1)  & a(MYC)  & ¬a(CCND1) 	 0.37369	Model 1401	GDSC
LUAD	CCT007093	null	null	57	6	d17p11.2 	d17p11.2 	 0.23475	Model 1101	GDSC
LUAD	CCT018159	null	null	60	6	a(CCND1) 	STK11  & d(CDKN2A)   |  d(CDKN2A)  & a(CCND1) 	 0.49924	Model 2201	GDSC
LUAD	Cetuximab	null	null	58	13	a(EGFR) 	BRAF  | EGFR  | d(SMARCA4)  | a(EGFR) 	 0.32741	Model 4101	GDSC
LUAD	CH5424802	null	null	60	18	a(TERT) 	¬SMARCA4  & TP53  & d(CDKN2A)  & ¬d(FAT1,IRF2) 	 0.42819	Model 1401	GDSC
LUAD	CHIR-99021	null	null	58	5	PI3K_only-UP 	BRAF  | PI3K_only-UP  | PI3K_only-DOWN  | TGFB-DOWN 	 0.50197	Model 4101	GDSC
LUAD	CP724714	null	null	60	9	a(MECOM) 	d(TFDP1)  & d(FAT1,IRF2)   |  ¬KRAS  & STK11 	 0.37132	Model 2201	GDSC
LUAD	CX-5461	null	null	60	25	a(TERT) 	KRAS  & ¬a(MET)  & ¬d(TFDP1)  & ¬MAPK_PI3K-UP 	 0.43812	Model 1401	GDSC
LUAD	Dasatinib	null	null	13	6	d(TFDP1) 	¬SMARCA4  & ¬a(FOXA2)  & ¬d(FAT1,IRF2) 	 0.10537	Model 1301	GDSC
LUAD	DMOG	null	null	58	8	RBM10 	d(CDKN2A)  & a(MYC) 	 0.49344	Model 1201	GDSC
LUAD	EKB-569	null	null	60	11	EGFR 	EGFR 	 0.22065	Model 1101	GDSC
LUAD	Epothilone_B	null	null	57	4	d18p11.21 	¬SMARCA4  & d(CDKN2A)  & a(MYC) 	 0.095226	Model 1301	GDSC
LUAD	Erlotinib	null	null	11	5	d(TFDP1) 	¬CTNNB1  & ¬KRAS  & ¬NF1  & ¬a(ARFGAP1) 	 0.54242	Model 1401	GDSC
LUAD	FR-180204	null	null	60	6	EGFR 	EGFR  & ¬a(CCND1) 	 0.11469	Model 1201	GDSC
LUAD	FTI-277	null	null	58	5	a(CCND1) 	a(ARFGAP1)  | PI3K_only-UP  | PI3K_only-DOWN 	 0.301	Model 3101	GDSC
LUAD	Gefitinib	null	null	52	8	EGFR 	EGFR  & ¬a(CCND1) 	 0.13665	Model 1201	GDSC
LUAD	Gemcitabine	null	null	58	5	MAPK_only-UP 	TP53  & MAPK_only-UP 	 0.51783	Model 1201	GDSC
LUAD	GSK-1904529A	null	null	58	5	a(MET) 	a(MET)  & a(MYC)   |  RBM10  & d19p12 	 0.46237	Model 2201	GDSC
LUAD	GSK269962A	null	null	60	5	a(ARFGAP1) 	¬STK11  & ¬a(CDK4)  & a(MYC) 	 0.53802	Model 1301	GDSC
LUAD	GSK-650394	null	null	58	5	SVEP1 	SVEP1 	 0.38744	Model 1101	GDSC
LUAD	GSK690693	null	null	60	9	d22q13.31 	EGFR  | HLA-A  | U2AF1  | d22q13.31 	 0.25676	Model 4101	GDSC
LUAD	GW_441756	null	null	52	11	ARID1A 	ARID1A  | d(SMARCA4)  | PI3K_only-UP  | Wnt-UP 	 0.44346	Model 4101	GDSC
LUAD	HG-5-88-01	null	null	33	6	d22q11.1 	EGFR  | KEAP1  | U2AF1  | d22q11.1 	 0.43538	Model 4101	GDSC
LUAD	IOX2	null	null	60	5	d(SMARCA4) 	CLASP2  | d(SMARCA4) 	 0.34477	Model 2101	GDSC
LUAD	JNK_Inhibitor_VIII	null	null	53	8	POLR2B 	KRAS  & ¬MAPK_PI3K-UP 	 0.22169	Model 1201	GDSC
LUAD	JQ12	null	null	58	6	d18p11.21 	¬a(CDK4)  & ¬a(ASXL1)  & a(MYC) 	 0.4999	Model 1301	GDSC
LUAD	KIN001-055	null	null	60	15	EGFR 	EGFR  | MAP4K3  | d22q13.31  | Wnt-DOWN 	 0.31842	Model 4101	GDSC
LUAD	KIN001-102	null	null	60	5	STK11 	¬KRAS  & STK11  & ¬d22q11.1  & ¬a(FOXA2) 	 0.41465	Model 1401	GDSC
LUAD	KIN001-260	null	null	60	10	a(TERT) 	d(CDKN2A)  & ¬d22q11.1  & ¬a(MYC)  & ¬d(FAT1,IRF2) 	 0.48481	Model 1401	GDSC
LUAD	KU-55933	null	null	53	5	CUL2 	CUL2 	 0.5	Model 1201	GDSC
LUAD	LAQ824	null	null	58	5	d17p11.2 	¬BRAF  & ¬d(PAX5)  & d17p11.2  & ¬a(CDK4) 	 0.51358	Model 1401	GDSC
LUAD	LY317615	null	null	59	9	d(SMARCA4) 	DDX3X  | MAP4K3  | STK11  | d(SMARCA4) 	 0.51813	Model 4101	GDSC
LUAD	Midostaurin	null	null	58	7	d17p11.2 	d17p11.2 	 0.41156	Model 1101	GDSC
LUAD	Mitomycin_C	null	null	58	9	a(KRAS) 	¬SMARCA4  & d(CDKN2A)  & ¬d13q14.2  & ¬d(FAT1,IRF2) 	 0.26032	Model 1401	GDSC
LUAD	Nutlin-3a	null	null	53	7	¬TP53 	¬TP53 	 0.13633	Model 1101	GDSC
LUAD	OSI-906	null	null	58	11	KEAP1 	KEAP1 	 0.51769	Model 1101	GDSC
LUAD	OSU-03012	null	null	58	6	d18p11.21 	d18p11.21 	 0.5042	Model 1101	GDSC
LUAD	PD-0325901	null	null	53	9	¬TP53 	¬CLASP2  & KRAS  & ¬d22q11.1 	 0.20651	Model 1301	GDSC
LUAD	PF-4708671	null	null	60	5	NF1 	¬SMARCA4  & ¬d(PAX5)  & d(FAT1,IRF2) 	 0.48802	Model 1301	GDSC
LUAD	QL-XI-92	null	null	60	15	STK11 	STK11  & ¬a(ARFGAP1) 	 0.31578	Model 1201	GDSC
LUAD	RDEA119__rescreen	null	null	60	5	RBM10 	KRAS  & d(TFDP1)   |  STK11  & ¬a(MYC) 	 0.30498	Model 2201	GDSC
LUAD	RO-3306	null	null	53	6	CDKN2A 	KRAS  & d(CDKN2A)   |  CTNNB1  & ¬PI3K_only-UP 	 0.44289	Model 2201	GDSC
LUAD	rTRAIL	null	null	59	18	STK11 	STK11 	 0.45062	Model 1101	GDSC
LUAD	Ruxolitinib	null	null	60	8	d(SMARCA4) 	d(SMARCA4) 	 0.31704	Model 1101	GDSC
LUAD	SB_216763	null	null	44	6	a(FOXA2) 	¬BRAF  & a(FOXA2)  & ¬d(FAT1,IRF2) 	 0.53765	Model 1301	GDSC
LUAD	SB52334	null	null	60	6	d17p11.2 	¬STK11  & ¬TP53  & ¬a(EGFR)  & ¬JAK-STAT-DOWN 	 0.45547	Model 1401	GDSC
LUAD	STF-62247	null	null	60	6	d22q13.31 	d22q11.1  & d22q13.31 	 0.51466	Model 1201	GDSC
LUAD	Thapsigargin	null	null	58	5	SVEP1 	¬SMARCA4  & SVEP1 	 0.51946	Model 1201	GDSC
LUAD	Tipifarnib	null	null	58	5	a(TERT) 	STK11  & PI3K_only-UP   |  a(TERT)  & ¬a(EGFR) 	 0.54767	Model 2201	GDSC
LUAD	TL-2-105	null	null	60	6	d(SMARCA4) 	d(SMARCA4)  | a(FUS,TAOK2)  | a(MECOM)  | VEGF-UP 	 0.35519	Model 4101	GDSC
LUAD	Trametinib	null	null	59	22	KRAS 	¬CTNNB1  & KRAS  & ¬d19p12  & ¬a(ASXL1) 	 0.16357	Model 1401	GDSC
LUAD	Tubastatin_A	null	null	60	9	TGFB-DOWN 	¬a(KRAS)  & ¬a(CDK4)  & ¬a(ASXL1)  & a(MYC) 	 0.51211	Model 1401	GDSC
LUAD	Vinorelbine	null	null	58	5	d17p11.2 	d18p11.21  | a(ARFGAP1)  | PI3K_only-DOWN  | TNFa-DOWN 	 0.49953	Model 4101	GDSC
LUAD	VX-11e	null	null	60	5	d17p11.2 	d17p11.2  & ¬d(FAT1,IRF2) 	 0.49732	Model 1201	GDSC
LUAD	WH-4-023	null	null	13	6	d18p11.21 	¬STK11  & ¬d(FAT1,IRF2) 	 0.12424	Model 1201	GDSC
LUAD	XAV_939	null	null	59	12	SVEP1 	SVEP1  | d(TFDP1) 	 0.50933	Model 2101	GDSC
LUAD	XMD14-99	null	null	60	5	BRAF 	¬KRAS  & ¬SMARCA4  & ¬a(MYC)  & ¬d(FAT1,IRF2) 	 0.10577	Model 1401	GDSC
LUAD	Y-39983	null	null	60	14	d17p11.2 	d(SMARCA4)  | d17p11.2  | a(CCND1) 	 0.36163	Model 3101	GDSC
LUSC	Afatinib	null	null	13	6	PIK3CA 	¬HRAS  & ¬a(CCT5,TERT,TRIO)  & ¬d13q13.1 	 0.19904	Model 1401	GDSC
LUSC	CX-5461	null	null	14	7	¬d(CDKN2A) 	¬d(CDKN2A) 	 0.088171	Model 1101	GDSC
LUSC	rTRAIL	null	null	15	9	d18q21.2 	d18q21.2 	 0.32283	Model 1101	GDSC
LUSC	Trametinib	null	null	15	6	d(SMARCA4) 	¬PBRM1  & ¬PIK3CA  & ¬a3q26.1  & ¬PI3K_only-UP 	 0.18793	Model 1401	GDSC
LUSC	Y-39983	null	null	14	5	¬d(CDKN2A) 	¬d(CDKN2A)   |  ¬a3q26.1  & MAPK_only-UP 	 0.14827	Model 2201	GDSC
OV	ABT-263	null	null	32	6	ARID1B 	ARID1A  & ¬TP53   |  ¬dXp22.32  & d8p21.3 	 0.19342	Model 2201	GDSC
OV	Afatinib	null	null	30	11	PIK3CA 	¬FBXW7  & ¬KRAS  & ¬a19q12  & ¬d18q22.1 	 0.30225	Model 1401	GDSC
OV	Afatinib__rescreen	null	null	32	9	CTNNB1 	ARID2  | CTNNB1  | TGFB-DOWN 	 0.32093	Model 3101	GDSC
OV	AMG-706	null	null	32	5	d15q25.2 	d15q25.2 	 0.31661	Model 1101	GDSC
OV	Bleomycin__50_uM	null	null	31	5	BRAF 	EP300  | MLL2  | VEGF-UP 	 0.414	Model 3101	GDSC
OV	Cetuximab	null	null	31	7	a(MYC) 	a(MYC) 	 0.39853	Model 1101	GDSC
OV	CX-5461	null	null	29	13	SMARCA4 	SMARCA4 	 0.52115	Model 1101	GDSC
OV	Elesclomol	null	null	30	7	dXq22.3 	EP300  | d19q13.32  | d15q25.2  | TGFB-DOWN 	 0.29931	Model 4101	GDSC
OV	Gefitinib	null	null	29	6	PIK3CA 	¬KRAS  & ¬a(CCNE1)  & ¬dXp22.32  & ¬d(ARID1B,MAP3K4,MLLT4) 	 0.24547	Model 1401	GDSC
OV	GSK690693	null	null	30	5	PIK3CA 	PIK3CA 	 0.021899	Model 1101	GDSC
OV	GW_441756	null	null	30	7	dXq22.3 	dXq22.3 	 0.23277	Model 1101	GDSC
OV	IOX2	null	null	31	6	CTNNB1 	BRAF  | CTNNB1  | Wnt-DOWN 	 0.27448	Model 3101	GDSC
OV	JNK_Inhibitor_VIII	null	null	32	5	PIK3R1 	ARID1A  & ¬PIK3CA   |  a(SOX17)  & ¬a3q27.1 	 0.4741	Model 2201	GDSC
OV	KIN001-260	null	null	29	5	d16q23.2 	¬SMARCA4  & TP53  & ¬a(KRAS)  & ¬d8p21.3 	 0.3175	Model 1401	GDSC
OV	MK-2206	null	null	31	5	ARID1A 	ARID1A 	 0.07011	Model 1101	GDSC
OV	Nutlin-3a	null	null	32	7	¬TP53 	¬TP53 	 0.12497	Model 1101	GDSC
OV	PD-0325901	null	null	32	8	d18q21.2 	KRAS  | a(TRIO)  | MAPK_only-UP  | JAK-STAT-DOWN 	 0.41049	Model 4101	GDSC
OV	QL-XII-61	null	null	22	6	PTEN 	KRAS  & ¬TP53   |  ¬SMAD4  & d(ARID1B,MAP3K4,MLLT4) 	 0.48948	Model 2201	GDSC
OV	rTRAIL	null	null	32	5	Wnt-UP 	Wnt-UP 	 0.56283	Model 1101	GDSC
OV	SB590885	null	null	32	5	d16q23.3 	¬TP53  & ¬d(ARID1B,MAP3K4,MLLT4)   |  d16q23.3  & ¬dXp21.1 	 0.53525	Model 2201	GDSC
OV	Trametinib	null	null	32	13	d18q21.2 	KRAS  | d21q22.3  | MAPK_only-UP  | PI3K_only-UP 	 0.32147	Model 4101	GDSC
OV	Tubastatin_A	null	null	29	5	a(MDM2,NUP107) 	¬KRAS  & ¬a(KRAS)  & ¬dXp21.1  & ¬d(ARID1B,MAP3K4,MLLT4) 	 0.42515	Model 1401	GDSC
OV	XAV_939	null	null	31	7	a(SOX17) 	a(SOX17)  | PI3K_only-UP  | JAK-STAT-DOWN 	 0.29728	Model 3101	GDSC
OV	Y-39983	null	null	30	7	KRAS 	BRAF  | EP300  | FBXW7  | SMARCA4 	 0.46626	Model 4101	GDSC
PAAD	AS605240	null	null	30	6	EP300 	¬SMAD4  & a(KRAS)  & ¬MAPK_PI3K-UP  & ¬TLR-DOWN 	 0.48675	Model 1401	GDSC
PAAD	AZD6244	null	null	28	9	a(WNK1) 	¬RNF43  & ¬d(CDKN2A)  & ¬MAPK_PI3K-UP 	 0.42145	Model 1301	GDSC
PAAD	BIRB_0796	null	null	23	5	TLR-DOWN 	¬ARID1A  & TLR-DOWN 	 0.5	Model 1201	GDSC
PAAD	BMS-536924	null	null	29	5	RNF43 	RNF43  | VEGF-DOWN 	 0.081107	Model 3101	GDSC
PAAD	BMS-708163	null	null	30	5	SMAD4 	SMAD4 	 0.48156	Model 1101	GDSC
PAAD	BMS-754807	null	null	30	7	TLR-UP 	SACS  | TLR-UP  | TLR-DOWN  | Wnt-DOWN 	 0.52296	Model 4101	GDSC
PAAD	CI-1040	null	null	25	6	TLR-DOWN 	TLR-DOWN 	 0.5	Model 1101	GDSC
PAAD	CX-5461	null	null	29	12	EP300 	CDKN2A  & ¬VEGF-UP 	 0.38988	Model 1201	GDSC
PAAD	Dabrafenib	null	null	25	5	Wnt-DOWN 	¬PBRM1  & RNF43   |  EP300  & a(KRAS) 	 0.21972	Model 2201	GDSC
PAAD	FH535	null	null	30	6	TLR-DOWN 	KRAS  & ¬SMAD4  & ¬a(KRAS)  & ¬TGFB-DOWN 	 0.36891	Model 1401	GDSC
PAAD	FMK	null	null	30	5	MAPK_PI3K-UP 	MAPK_PI3K-UP 	 0.54736	Model 1101	GDSC
PAAD	FR-180204	null	null	29	5	EP300 	EP300 	 0.56541	Model 1101	GDSC
PAAD	GW-2580	null	null	29	5	CDKN2A 	CDKN2A  | a18q11.1 	 0.54911	Model 2101	GDSC
PAAD	JQ1	null	null	27	6	¬KRAS 	¬SMAD4  & ¬a(KRAS)  & d(CDKN2A) 	 0.35581	Model 1301	GDSC
PAAD	OSI-906	null	null	30	7	TLR-UP 	SMAD4  & ¬Wnt-DOWN 	 0.50335	Model 1201	GDSC
PAAD	PD-0325901	null	null	22	11	ARID1A 	KRAS  & ¬a(KRAS)  & ¬PI3K_only-UP  & ¬TGFB-DOWN 	 0.16545	Model 1401	GDSC
PAAD	QL-XI-92	null	null	29	8	MAPK_PI3K-UP 	MAPK_PI3K-UP  | VEGF-DOWN 	 0.50793	Model 2101	GDSC
PAAD	RDEA119	null	null	21	6	VEGF-DOWN 	¬MAP2K4  & TP53  & ¬a(KRAS)  & ¬TGFB-DOWN 	 0.46835	Model 1401	GDSC
PAAD	RDEA119__rescreen	null	null	26	5	EP300 	EP300  & a(KRAS) 	 0.53462	Model 1201	GDSC
PAAD	rTRAIL	null	null	27	10	EP300 	¬ARID1A  & ¬FBXW7  & ¬a18q11.1  & d(CDKN2A) 	 0.17391	Model 1401	GDSC
PAAD	Trametinib	null	null	25	18	RNF43 	¬d(CDKN2A)  & ¬MAPK_PI3K-UP  & ¬VEGF-UP 	 0.35099	Model 1301	GDSC
PAAD	Tubastatin_A	null	null	29	5	CDKN2A 	CDKN2A  & ¬SMAD4  & ¬VEGF-UP 	 0.48292	Model 1301	GDSC
PAAD	VX-11e	null	null	29	7	CDKN2A 	ARID1A  | EP300  | RNF43 	 0.45925	Model 4101	GDSC
PAAD	XAV_939	null	null	27	5	PI3K_only-UP 	SACS  | Wnt-DOWN 	 0.42888	Model 2101	GDSC
PAAD	Y-39983	null	null	29	5	EP300 	EP300  & a(KRAS)   |  CDKN2A  & TP53 	 0.50187	Model 2201	GDSC
PANCAN	17-AAG	null	null	837	45	BRAF 	BRAF 	 0.47996	Model 1101	GDSC
PANCAN	5-Fluorouracil	null	null	894	90	JAK-STAT-UP 	d19q13.43  | JAK-STAT-UP  | TLR-UP 	 0.37913	Model 3101	GDSC
PANCAN	_5Z_-7-Oxozeaenol	null	null	902	118	BRAF 	BRAF  | CDKN1B  | NRAS  | JAK-STAT-UP 	 0.21784	Model 4101	GDSC
PANCAN	681640	null	null	747	68	d(FGFR3),d4p16.3 	d(FGFR3),d4p16.3 	 0.4943	Model 1101	GDSC
PANCAN	A-443654	null	null	388	33	MLL2 	MLL2  | PIK3CA  | d21q11.2 	 0.4868	Model 3101	GDSC
PANCAN	A-770041	null	null	389	154	d(APC) 	BCR-ABL  | CREBBP  | NF2  | NOTCH1 	 0.4836	Model 4101	GDSC
PANCAN	ABT-263	null	null	836	224	TNFa-DOWN 	d(CHD3,GPS2,TP53)  | JAK-STAT-UP  | TLR-UP  | TNFa-DOWN 	 0.34059	Model 4101	GDSC
PANCAN	ABT-869	null	null	902	96	JAK-STAT-UP 	CDKN1B  | FLT3  | d12p12.3 	 0.42319	Model 3101	GDSC
PANCAN	ABT-888	null	null	834	109	EP300 	EP300  | a9p24.1  | JAK-STAT-UP  | TLR-UP 	 0.47143	Model 4101	GDSC
PANCAN	AC220	null	null	901	137	JAK-STAT-UP 	d(CREBBP)  | d12p12.3  | H2O2-DOWN  | MAPK_only-DOWN 	 0.44184	Model 4101	GDSC
PANCAN	Afatinib	null	null	833	154	a(CDK12,ERBB2,MED24) 	a(EGFR)  | a(CDK12,ERBB2,MED24) 	 0.33737	Model 2101	GDSC
PANCAN	Afatinib__rescreen	null	null	901	142	a(CDK12,ERBB2,MED24) 	d8p23.1  | a(CDK12,ERBB2,MED24)  | Wnt-DOWN 	 0.374	Model 3101	GDSC
PANCAN	AG-014699	null	null	906	75	EWSR1-FLI1 	EWSR1-FLI1  | d16p13.3  | TLR-DOWN 	 0.43722	Model 3101	GDSC
PANCAN	AICAR	null	null	824	88	JAK-STAT-UP 	NOTCH1  | d(SDHD)  | d(GNAQ,NTRK2,PCSK5,TJP2)  | JAK-STAT-UP 	 0.46196	Model 4101	GDSC
PANCAN	AKT_inhibitor_VIII	null	null	860	77	PIK3CA 	FGFR2  | PIK3CA  | a(EGFR) 	 0.4022	Model 3101	GDSC
PANCAN	AMG-706	null	null	836	101	TGFB-UP 	¬a(EGFR)  & d(BNC2,CDKN2A,JAK2,PSIP1)  & ¬d(SRGAP3)  & dXp11.3 	 0.39296	Model 1401	GDSC
PANCAN	AP-24534	null	null	863	87	JAK-STAT-UP 	¬d3p14.2  & dXq22.3 	 0.32352	Model 1201	GDSC
PANCAN	AR-42	null	null	891	77	JAK-STAT-UP 	JAK-STAT-UP 	 0.42662	Model 1101	GDSC
PANCAN	AS601245	null	null	851	76	d21q11.2 	CTNND1  | a(CLTC,PPM1D)  | d21q11.2 	 0.42618	Model 3101	GDSC
PANCAN	AS605240	null	null	898	111	NRAS 	BRAF  | NRAS  | JAK-STAT-UP 	 0.2601	Model 3101	GDSC
PANCAN	AT-7519	null	null	899	53	JAK-STAT-UP 	a(INPP4A)  | JAK-STAT-UP  | MAPK_only-DOWN 	 0.38912	Model 3101	GDSC
PANCAN	ATRA	null	null	824	90	JAK-STAT-UP 	¬d3p14.2  & dXq21.33 	 0.39283	Model 1201	GDSC
PANCAN	AUY922	null	null	845	53	a(ARFGAP1,GNAS) 	¬d(ARID1B,MAP3K4,MLLT4)  & dXp11.3  & ¬d(ERCC3)  & ¬d20p12.1 	 0.48074	Model 1401	GDSC
PANCAN	AV-951	null	null	900	111	ASXL1 	¬d3p14.2  & dXq28 	 0.39864	Model 1201	GDSC
PANCAN	Axitinib	null	null	831	69	BCR-ABL 	ASXL1  | BCR-ABL  | SMARCA4  | IL-1-DOWN 	 0.36098	Model 4101	GDSC
PANCAN	AZ628	null	null	393	65	BRAF 	BRAF  | KRAS  | NRAS  | JAK-STAT-UP 	 0.25172	Model 4101	GDSC
PANCAN	AZD-0530	null	null	396	62	NOTCH1 	BCR-ABL  | NOTCH1 	 0.34692	Model 2101	GDSC
PANCAN	AZD6244	null	null	908	130	BRAF 	BRAF  | KRAS  | NRAS  | PML-RARA 	 0.21964	Model 4101	GDSC
PANCAN	AZD6482	null	null	886	114	VHL 	¬d(BNC2,CDKN2A,JAK2,PSIP1)  & ¬d3p14.2  & ¬dXp21.1 	 0.48574	Model 1301	GDSC
PANCAN	AZD7762	null	null	833	61	d17p11.2 	¬d3p14.2  & dXq22.3 	 0.29631	Model 1201	GDSC
PANCAN	AZD8055	null	null	828	91	MLL2 	¬d(CACNA1D,WNT5A),d3p21.1  & dXq28  & ¬d21q11.2 	 0.4414	Model 1301	GDSC
PANCAN	BAY_61-3606	null	null	851	68	FLT3 	¬TP53  & dXq28   |  BRAF  & ¬a(ARFGAP1,GNAS) 	 0.34328	Model 2201	GDSC
PANCAN	Bexarotene	null	null	842	64	TET2 	TET2 	 0.46581	Model 1101	GDSC
PANCAN	BI-2536	null	null	387	30	d(SMAD4),d18q21.2 	TP53  & d(BNC2,CDKN2A,JAK2,PSIP1)  & ¬dXq22.3 	 0.39899	Model 1301	GDSC
PANCAN	Bicalutamide	null	null	865	82	a(CCNE1) 	¬d8p21.1  & ¬d16q23.1  & dXp22.32 	 0.52098	Model 1301	GDSC
PANCAN	BIRB_0796	null	null	826	102	d(FGFR3),d4p16.3 	MACF1  | d(FGFR3),d4p16.3  | d20p12.1  | d15q25.2 	 0.4563	Model 4101	GDSC
PANCAN	BIX02189	null	null	900	112	JAK-STAT-UP 	MLL2  | JAK-STAT-UP 	 0.3094	Model 2101	GDSC
PANCAN	Bleomycin__50_uM	null	null	922	149	SMARCA4 	CASP8  | NF2  | SMARCA4  | IL-1-UP 	 0.43608	Model 4101	GDSC
PANCAN	Bleomycin	null	null	846	71	d8p23.1 	¬BRAF  & ¬TP53  & ¬d(SYNCRIP,ZNF292) 	 0.44107	Model 1301	GDSC
PANCAN	BMN-673	null	null	901	100	EWSR1-FLI1 	EWSR1-FLI1  | TLR-DOWN 	 0.39321	Model 2101	GDSC
PANCAN	BMS-345541	null	null	903	125	JAK-STAT-UP 	TET2  | JAK-STAT-UP  | IL-1-DOWN  | MAPK_only-DOWN 	 0.32696	Model 4101	GDSC
PANCAN	BMS-509744	null	null	389	30	d(SMAD4),d18q21.2 	¬MLL2  & ¬d(CHD9,CNOT1,CYLD,MMP2,NUP93)  & d(SYNCRIP,ZNF292)  & ¬TNFa-DOWN 	 0.37445	Model 1401	GDSC
PANCAN	BMS-536924	null	null	912	103	EWSR1-FLI1 	EWSR1-FLI1  & ¬d3q13.33   |  ¬TP53  & d(ATRX) 	 0.46802	Model 2201	GDSC
PANCAN	BMS-708163	null	null	911	95	d1p35.3 	¬d(SDHD)  & d(BNC2,CDKN2A,JAK2,PSIP1)  & dXq21.33 	 0.47961	Model 1301	GDSC
PANCAN	BMS-754807	null	null	850	114	KRAS 	EWSR1-FLI1  | KRAS 	 0.37297	Model 2101	GDSC
PANCAN	Bortezomib	null	null	391	31	d(ARID1B,MAP3K4,MLLT4) 	d(SYNCRIP,ZNF292)  & ¬dXp21.1  & ¬TNFa-DOWN 	 0.41969	Model 1301	GDSC
PANCAN	Bosutinib	null	null	835	81	BCR-ABL 	BCR-ABL  | EP300  | a(EGFR) 	 0.44747	Model 3101	GDSC
PANCAN	Bryostatin_1	null	null	850	103	BRAF 	¬TP53  & d(ATRX)   |  a(AHR,HDAC9)  & ¬d(BNC2,CDKN2A,JAK2,PSIP1) 	 0.49276	Model 2201	GDSC
PANCAN	BX-795	null	null	836	79	JAK-STAT-UP 	¬KRAS  & ¬d18q22.1  & ¬d(CACNA1D,WNT5A),d3p21.1  & dXq21.33 	 0.39828	Model 1401	GDSC
PANCAN	BX-912	null	null	901	116	JAK-STAT-UP 	TP53BP1  & ¬d20p12.1   |  ¬d3p14.2  & dXq28 	 0.39194	Model 2201	GDSC
PANCAN	CAL-101	null	null	903	126	MAPK_only-DOWN 	ARID4A  | JAK-STAT-UP  | MAPK_only-DOWN 	 0.34097	Model 3101	GDSC
PANCAN	Camptothecin	null	null	833	64	MLL2 	MLL2  | MAPK_only-DOWN 	 0.31233	Model 2101	GDSC
PANCAN	CAY10603	null	null	895	89	JAK-STAT-UP 	JAK-STAT-UP  | MAPK_only-DOWN 	 0.36845	Model 2101	GDSC
PANCAN	CCT007093	null	null	907	102	a20q13.13 	d1p36.12  | a20q13.13 	 0.40081	Model 2101	GDSC
PANCAN	CCT018159	null	null	883	66	PTEN 	PTEN  | a(CCND1,CTTN) 	 0.44296	Model 2101	GDSC
PANCAN	CEP-701	null	null	833	80	JAK-STAT-UP 	¬d3p14.2  & dXq28 	 0.44763	Model 1201	GDSC
PANCAN	Cetuximab	null	null	862	121	a(EGFR) 	dXp11.3  & ¬dXq28   |  a(EGFR)  & ¬a(MET) 	 0.44831	Model 2201	GDSC
PANCAN	CGP-082996	null	null	388	29	d18q22.1 	d18q22.1  & ¬dXp11.3 	 0.45818	Model 1201	GDSC
PANCAN	CGP-60474	null	null	388	31	d(BMPR1A,FAS,PTEN) 	d(BNC2,CDKN2A,JAK2,PSIP1)  & d(SYNCRIP,ZNF292) 	 0.4236	Model 1201	GDSC
PANCAN	CH5424802	null	null	899	163	d2q32.1 	¬d8p23.3  & d(ATRX) 	 0.47626	Model 1201	GDSC
PANCAN	CHIR-99021	null	null	901	93	NF2 	¬TP53  & ¬d18q22.1  & ¬d(CASP1),d11q22.3  & ¬a(IL7R) 	 0.39987	Model 1401	GDSC
PANCAN	CI-1040	null	null	824	121	BRAF 	BRAF  | NRAS  | JAK-STAT-UP 	 0.25118	Model 3101	GDSC
PANCAN	Cisplatin	null	null	834	81	TLR-DOWN 	¬TP53  & ¬a(MYC)  & ¬d16q23.1 	 0.35962	Model 1301	GDSC
PANCAN	CMK	null	null	388	25	MAPK_only-DOWN 	¬d(FAT1,IRF2)  & ¬d(CHD3,GPS2,TP53)  & dXq28  & ¬d(ERCC3) 	 0.2804	Model 1401	GDSC
PANCAN	CP466722	null	null	903	83	JAK-STAT-UP 	¬d3p14.2  & MAPK_only-DOWN   |  ¬d3p14.2  & dXq28 	 0.32674	Model 2201	GDSC
PANCAN	CP724714	null	null	902	117	a(CDK12,ERBB2,MED24) 	a(CDK12,ERBB2,MED24) 	 0.31708	Model 1101	GDSC
PANCAN	Crizotinib	null	null	395	49	d(CHD9,CNOT1,CYLD,MMP2,NUP93) 	¬d(SDHD)  & ¬d(ARID1B,MAP3K4,MLLT4)  & ¬d17p13.1  & dXq21.33 	 0.4735	Model 1401	GDSC
PANCAN	CUDC-101	null	null	883	78	JAK-STAT-UP 	¬d(BNC2,CDKN2A,JAK2,PSIP1)  & dXq22.3 	 0.43487	Model 1201	GDSC
PANCAN	CX-5461	null	null	898	506	MLL2 	MLL2  | a(MYCN)  | JAK-STAT-UP  | MAPK_only-DOWN 	 0.37184	Model 4101	GDSC
PANCAN	Cyclopamine	null	null	386	62	CREBBP 	¬d(CHD3,GPS2,TP53)  & dXq28  & ¬d(PABPC3,SACS,ZMYM2) 	 0.39672	Model 1301	GDSC
PANCAN	Cytarabine	null	null	830	77	MLL2 	MLL2 	 0.38929	Model 1101	GDSC
PANCAN	Dabrafenib	null	null	860	144	BRAF 	BRAF 	 0.16409	Model 1101	GDSC
PANCAN	Dasatinib	null	null	385	130	BCR-ABL 	¬TP53  & d(BNC2,CDKN2A,JAK2,PSIP1)  & ¬d1p35.3 	 0.47322	Model 1301	GDSC
PANCAN	DMOG	null	null	860	73	d(PCDH18) 	d(STK11)  | d(PCDH18)  | a(PIP5K1A,SETDB1)  | a(INPP4A) 	 0.43956	Model 4101	GDSC
PANCAN	Docetaxel	null	null	834	65	a(AHR,HDAC9) 	d(FAT1,IRF2)  & ¬d17p13.2  & dXp21.1 	 0.39402	Model 1301	GDSC
PANCAN	Doxorubicin	null	null	854	58	EWSR1-FLI1 	d18q22.1  & ¬d16q23.1 	 0.44569	Model 1201	GDSC
PANCAN	EHT_1864	null	null	909	84	SMARCA4 	TP53  & ¬a(KRAS)  & ¬d(SYNCRIP,ZNF292)  & ¬dXp21.1 	 0.46064	Model 1401	GDSC
PANCAN	EKB-569	null	null	901	121	JAK-STAT-UP 	EGFR  | JAK-STAT-UP 	 0.41699	Model 2101	GDSC
PANCAN	Elesclomol	null	null	833	58	SMARCA4 	¬TP53  & d3p14.2   |  d(FAT1,IRF2)  & dXq22.3 	 0.4434	Model 2201	GDSC
PANCAN	Embelin	null	null	855	64	BRAF 	¬d(SYNCRIP,ZNF292)  & VEGF-UP   |  ¬d(FAT1,IRF2)  & dXq28 	 0.44739	Model 2201	GDSC
PANCAN	Epothilone_B	null	null	854	61	a(MYC) 	a(MYC)  & d(BNC2,CDKN2A,JAK2,PSIP1) 	 0.35366	Model 1201	GDSC
PANCAN	Erlotinib	null	null	362	66	d3p14.2 	¬d16q23.1  & d2q32.1   |  ¬d(BMPR1A,FAS,PTEN)  & d3p14.2 	 0.46948	Model 2201	GDSC
PANCAN	Etoposide	null	null	864	56	MLL2 	¬TP53  & ¬d16q23.1  & ¬H2O2-UP 	 0.46332	Model 1301	GDSC
PANCAN	EX-527	null	null	897	100	JAK-STAT-UP 	JAK-STAT-UP 	 0.50585	Model 1101	GDSC
PANCAN	FH535	null	null	851	74	BRAF 	BRAF  | CTNNB1  | d11q24.2  | a(RHEB) 	 0.46719	Model 4101	GDSC
PANCAN	FK866	null	null	887	12	a(FGFR1,WHSC1L1) 	EWSR1-FLI1  | d(CHD9,CNOT1,CYLD,MMP2,NUP93)  | MAPK_PI3K-DOWN 	 0.42702	Model 3101	GDSC
PANCAN	FMK	null	null	777	113	JAK-STAT-UP 	NRAS  & ¬d(SDHD)   |  ¬DDX3X  & JAK-STAT-UP 	 0.34776	Model 2201	GDSC
PANCAN	FR-180204	null	null	900	109	JAK-STAT-UP 	JAK-STAT-UP 	 0.38748	Model 1101	GDSC
PANCAN	FTI-277	null	null	863	96	d(ERCC3) 	d(MED17)  | d5q12.1  | a(CLTC,PPM1D)  | a(BCL11A,REL,XPO1) 	 0.46672	Model 4101	GDSC
PANCAN	GDC0941	null	null	828	80	MLL2 	MLL2 	 0.46877	Model 1101	GDSC
PANCAN	GDC0941__rescreen	null	null	875	82	MAPK_only-DOWN 	MLL2  | MAPK_only-DOWN 	 0.41109	Model 2101	GDSC
PANCAN	Gefitinib	null	null	830	120	a(EGFR) 	a(EGFR)  & ¬a(RHEB) 	 0.36122	Model 1201	GDSC
PANCAN	Gemcitabine	null	null	849	55	MAPK_only-DOWN 	d16q23.1  & ¬d3p14.2 	 0.45634	Model 1201	GDSC
PANCAN	Genentech_Cpd_10	null	null	903	95	JAK-STAT-UP 	a(MYCN)  | JAK-STAT-UP  | MAPK_only-DOWN  | MAPK_PI3K-DOWN 	 0.36183	Model 4101	GDSC
PANCAN	GNF-2	null	null	386	48	BCR-ABL 	ASPM  | BCR-ABL  | IL-1-DOWN 	 0.34976	Model 3101	GDSC
PANCAN	GSK1070916	null	null	875	151	JAK-STAT-UP 	MLL2  | JAK-STAT-UP  | MAPK_only-DOWN  | TNFa-DOWN 	 0.36484	Model 4101	GDSC
PANCAN	GSK-1904529A	null	null	854	114	a(RAD21) 	ARID1A  | a(RAD21) 	 0.4664	Model 2101	GDSC
PANCAN	GSK2126458	null	null	902	104	MAPK_only-DOWN 	PTPN11  | XPO1  | JAK-STAT-UP  | MAPK_only-DOWN 	 0.41234	Model 4101	GDSC
PANCAN	GSK269962A	null	null	914	110	PTEN 	¬d8p21.1  & ¬d(SRGAP3)  & dXq28 	 0.41853	Model 1301	GDSC
PANCAN	GSK429286A	null	null	903	121	JAK-STAT-UP 	d19q13.43  | d14q24.1  | JAK-STAT-UP  | MAPK_PI3K-DOWN 	 0.409	Model 4101	GDSC
PANCAN	GSK-650394	null	null	845	73	a(MYC) 	CTNNB1  | FLT3  | XRN1  | a(MYC) 	 0.3926	Model 4101	GDSC
PANCAN	GSK690693	null	null	900	314	PTEN 	PIK3CA  | PTEN  | JAK-STAT-UP  | MAPK_only-DOWN 	 0.3599	Model 4101	GDSC
PANCAN	GW-2580	null	null	902	112	d12p12.3 	MLL2  | d12p12.3  | a(MACF1) 	 0.44045	Model 3101	GDSC
PANCAN	GW_441756	null	null	831	112	d20p12.1 	¬TP53  & ¬d8p23.3  & ¬d(FAT1,IRF2) 	 0.41952	Model 1301	GDSC
PANCAN	GW843682X	null	null	389	15	a(KRAS) 	d16q23.1  & ¬dXp21.1   |  d(BNC2,CDKN2A,JAK2,PSIP1)  & JAK-STAT-UP 	 0.28978	Model 2201	GDSC
PANCAN	HG-5-113-01	null	null	487	40	a(MYCN) 	EWSR1-FLI1  | XRN1  | a(MYCN) 	 0.4284	Model 3101	GDSC
PANCAN	HG-5-88-01	null	null	486	57	a2p24.1 	¬d3p22.1  & d(ATRX)  & ¬d(ERCC3) 	 0.40558	Model 1301	GDSC
PANCAN	HG-6-64-1	null	null	859	69	d(CHD3,GPS2,TP53) 	ASXL1  & ¬d(FAT1,IRF2)   |  ¬d3p14.2  & dXq28 	 0.39809	Model 2201	GDSC
PANCAN	I-BET_151	null	null	898	164	JAK-STAT-UP 	MLL2  | JAK-STAT-UP  | MAPK_only-DOWN 	 0.29529	Model 3101	GDSC
PANCAN	Imatinib	null	null	396	54	BCR-ABL 	BCR-ABL 	 0.36565	Model 1101	GDSC
PANCAN	IOX2	null	null	915	114	PTEN 	EZH2  | NF2  | PTEN 	 0.46583	Model 3101	GDSC
PANCAN	IPA-3	null	null	853	49	JAK-STAT-UP 	JAK-STAT-UP  | MAPK_only-DOWN 	 0.47467	Model 2101	GDSC
PANCAN	JNJ-26854165	null	null	903	70	JAK-STAT-UP 	¬TP53  & ¬d18q22.1  & ¬d3p14.2 	 0.35041	Model 1301	GDSC
PANCAN	JNK-9L	null	null	863	73	d20p12.1 	¬d18q21.31  & d16q23.1  & d(BNC2,CDKN2A,JAK2,PSIP1)  & ¬TGFB-UP 	 0.42071	Model 1401	GDSC
PANCAN	JNK_Inhibitor_VIII	null	null	834	100	a(IL7R) 	¬d(BNC2,CDKN2A,JAK2,PSIP1)  & a(IL7R)   |  d(MED17)  & d(BNC2,CDKN2A,JAK2,PSIP1) 	 0.51602	Model 2201	GDSC
PANCAN	JQ12	null	null	857	83	d(MED17) 	¬TP53  & dXq28   |  d(MED17)  & ¬dXp21.1 	 0.40958	Model 2201	GDSC
PANCAN	JQ1	null	null	901	167	JAK-STAT-UP 	JAK-STAT-UP  | TLR-UP  | Wnt-UP  | MAPK_PI3K-DOWN 	 0.35917	Model 4101	GDSC
PANCAN	JW-7-24-1	null	null	902	127	MAPK_only-DOWN 	MLL2  | JAK-STAT-UP  | MAPK_only-DOWN 	 0.37649	Model 3101	GDSC
PANCAN	JW-7-52-1	null	null	374	29	a8q24.13 	d22q11.1  | d(ING1,IRS2,TFDP1)  | PI3K_only-UP 	 0.46045	Model 3101	GDSC
PANCAN	KIN001-055	null	null	900	100	d8p23.1 	d8p23.3  & ¬d(SYNCRIP,ZNF292) 	 0.48571	Model 1201	GDSC
PANCAN	KIN001-102	null	null	902	100	MAPK_only-DOWN 	JAK-STAT-UP  | H2O2-DOWN  | MAPK_only-DOWN 	 0.32557	Model 3101	GDSC
PANCAN	KIN001-135	null	null	392	42	a(DHX9) 	¬d18q22.1  & ¬d(CASP1),d11q22.3  & ¬d(CHD9,CNOT1,CYLD,MMP2,NUP93)  & dXp21.1 	 0.46566	Model 1401	GDSC
PANCAN	KIN001-236	null	null	900	121	JAK-STAT-UP 	XPO1  | JAK-STAT-UP  | MAPK_only-DOWN  | MAPK_PI3K-DOWN 	 0.3657	Model 4101	GDSC
PANCAN	KIN001-244	null	null	899	94	JAK-STAT-UP 	MLL2  | JAK-STAT-UP  | MAPK_only-DOWN 	 0.27283	Model 3101	GDSC
PANCAN	KIN001-260	null	null	899	244	JAK-STAT-UP 	MLL2  | JAK-STAT-UP  | TLR-UP  | MAPK_only-DOWN 	 0.34711	Model 4101	GDSC
PANCAN	KIN001-266	null	null	900	87	JAK-STAT-UP 	PCSK5  | d(CACNA1D,WNT5A),d3p21.1  | JAK-STAT-UP 	 0.48737	Model 3101	GDSC
PANCAN	KIN001-270	null	null	900	110	Wnt-UP 	¬d(SMAD4),d18q21.2  & ¬d(CACNA1D,WNT5A),d3p21.1  & dXq28 	 0.41342	Model 1301	GDSC
PANCAN	KU-55933	null	null	835	90	TET2 	MLL2  | TET2 	 0.44364	Model 2101	GDSC
PANCAN	Lapatinib	null	null	387	60	d(SMAD4),d18q21.2 	TP53  & d18q22.1  & ¬d(BMPR1A,FAS,PTEN) 	 0.41335	Model 1301	GDSC
PANCAN	LAQ824	null	null	855	81	JAK-STAT-UP 	MLL-AFF1  | d(CHD3,GPS2,TP53)  | JAK-STAT-UP  | MAPK_only-DOWN 	 0.41714	Model 4101	GDSC
PANCAN	Lenalidomide	null	null	835	109	d(ATP1A1,CSDE1,NRAS) 	d16q23.1  & ¬a(KRAS)  & ¬d4q22.1  & ¬d21q11.2 	 0.36261	Model 1401	GDSC
PANCAN	LFM-A13	null	null	853	95	SMARCA4 	¬d18q21.31  & dXq28  & ¬d21q11.2 	 0.50971	Model 1301	GDSC
PANCAN	LY317615	null	null	901	97	MLL2 	¬d3p14.1  & MAPK_only-DOWN   |  BRCA2  & ¬POLR2B 	 0.47894	Model 2201	GDSC
PANCAN	Masitinib	null	null	901	94	JAK-STAT-UP 	¬d3p14.2  & dXq28  & ¬d21q11.2 	 0.32762	Model 1301	GDSC
PANCAN	Methotrexate	null	null	833	124	JAK-STAT-UP 	MLL2  | JAK-STAT-UP  | TLR-UP  | MAPK_PI3K-DOWN 	 0.3207	Model 4101	GDSC
PANCAN	MG-132	null	null	390	28	a(MET) 	a(CHD9,CYLD)  | a(RHEB)  | d(ARID1B,MAP3K4,MLLT4)  | VEGF-UP 	 0.4007	Model 4101	GDSC
PANCAN	Midostaurin	null	null	864	72	TGFB-UP 	¬d(FAT1,IRF2)  & dXq22.3 	 0.39933	Model 1201	GDSC
PANCAN	Mitomycin_C	null	null	855	72	MAPK_only-UP 	¬d18q22.1  & ¬d8p23.3  & d(BNC2,CDKN2A,JAK2,PSIP1)  & ¬d(SYNCRIP,ZNF292) 	 0.49386	Model 1401	GDSC
PANCAN	MK-2206	null	null	812	98	H2O2-DOWN 	¬d18q22.1  & d16q23.1  & ¬d(FAT1,IRF2) 	 0.46222	Model 1301	GDSC
PANCAN	MLN4924	null	null	693	45	d(ERCC3) 	¬d(ARID1B,MAP3K4,MLLT4)  & ¬d3p22.1  & d3p14.2 	 0.48334	Model 1301	GDSC
PANCAN	MP470	null	null	896	129	d(RPL22) 	¬TP53  & d(BNC2,CDKN2A,JAK2,PSIP1)  & ¬d(ARID1B,MAP3K4,MLLT4)  & ¬H2O2-UP 	 0.47186	Model 1401	GDSC
PANCAN	MPS-1-IN-1	null	null	898	63	TGFB-DOWN 	EWSR1-FLI1  | d7q31.1  | a(PIP5K1A,SETDB1)  | a(MDM4,PIK3C2B,ZC3H11A) 	 0.40435	Model 4101	GDSC
PANCAN	MS-275	null	null	391	24	d(EXT2) 	d(EXT2)  & ¬dXp11.3 	 0.45787	Model 1201	GDSC
PANCAN	NG-25	null	null	900	90	JAK-STAT-UP 	¬KRAS  & ¬d3p22.1  & d(ATRX)  & ¬d21q11.2 	 0.32455	Model 1401	GDSC
PANCAN	Nilotinib	null	null	790	117	BCR-ABL 	¬a(CCT5,TERT,TRIO)  & ¬d3p14.2  & dXp11.3  & ¬d21q11.2 	 0.31911	Model 1401	GDSC
PANCAN	NPK76-II-72-1	null	null	900	84	JAK-STAT-UP 	MLL2  | JAK-STAT-UP  | MAPK_only-DOWN 	 0.28625	Model 3101	GDSC
PANCAN	NSC-207895	null	null	895	53	d(ING1,IRS2,TFDP1) 	¬KRAS  & ¬d18q21.31  & d16q23.1  & ¬d21q11.2 	 0.48617	Model 1401	GDSC
PANCAN	NSC-87877	null	null	859	101	a(IL7R) 	TP53  & ¬d(ARID1B,MAP3K4,MLLT4)  & dXp11.3 	 0.50508	Model 1301	GDSC
PANCAN	NU-7441	null	null	833	68	MLL2 	MLL2  | a(CUL2,EPC1) 	 0.42567	Model 2101	GDSC
PANCAN	Nutlin-3a	null	null	836	232	¬TP53 	CTNNB1  | ¬TP53 	 0.14539	Model 2101	GDSC
PANCAN	NVP-BEZ235	null	null	829	64	MYH11 	MYH11  | a7q22.1  | VEGF-UP  | MAPK_only-DOWN 	 0.46911	Model 4101	GDSC
PANCAN	NVP-BHG712	null	null	900	103	JAK-STAT-UP 	ASXL1  | MLL2  | JAK-STAT-UP  | MAPK_only-DOWN 	 0.2877	Model 4101	GDSC
PANCAN	NVP-TAE684	null	null	395	39	d12q24.32 	d16q23.1  & ¬d(ERCC3)  & ¬d(PABPC3,SACS,ZMYM2)  & ¬TLR-UP 	 0.41038	Model 1401	GDSC
PANCAN	Obatoclax_Mesylate	null	null	847	64	BRAF 	BRAF  | a(CCND1,CTTN) 	 0.39808	Model 2101	GDSC
PANCAN	Olaparib	null	null	892	91	EWSR1-FLI1 	EWSR1-FLI1  | EWSR1-X  | TLR-DOWN 	 0.40413	Model 3101	GDSC
PANCAN	OSI-027	null	null	896	62	MLL2 	MLL2 	 0.38429	Model 1101	GDSC
PANCAN	OSI-906	null	null	850	122	EWSR1-FLI1 	EWSR1-FLI1  | KRAS  | NOTCH1  | a(MYCN) 	 0.36402	Model 4101	GDSC
PANCAN	OSI-930	null	null	901	110	JAK-STAT-UP 	¬d(LARP4B)  & ¬d(CACNA1D,WNT5A),d3p21.1  & dXq22.3  & ¬d20p12.1 	 0.33972	Model 1401	GDSC
PANCAN	OSU-03012	null	null	853	73	EP300 	a(MYC)  & dXp11.3   |  SACS  & ¬d8p23.3 	 0.44556	Model 2201	GDSC
PANCAN	PAC-1	null	null	842	61	JAK-STAT-UP 	¬d(FAT1,IRF2)  & ¬d(ARID1B,MAP3K4,MLLT4)  & dXq28 	 0.35209	Model 1301	GDSC
PANCAN	Paclitaxel	null	null	389	24	d18q21.31 	d18q22.1  & ¬dXq22.3 	 0.21531	Model 1201	GDSC
PANCAN	Parthenolide	null	null	392	34	MLL2 	MLL2  & ¬a(CCT5,TERT,TRIO) 	 0.44782	Model 1201	GDSC
PANCAN	Pazopanib	null	null	851	91	TGFB-UP 	CDKN1B  | FGFR2  | TGFB-UP 	 0.43166	Model 3101	GDSC
PANCAN	PD-0325901	null	null	828	138	BRAF 	BRAF  | KRAS  | NRAS 	 0.20236	Model 3101	GDSC
PANCAN	PD-0332991	null	null	812	63	JAK-STAT-UP 	¬a(MYC)  & d(BNC2,CDKN2A,JAK2,PSIP1)  & ¬d(FAT1,IRF2)  & ¬d3p14.2 	 0.43432	Model 1401	GDSC
PANCAN	PD-173074	null	null	836	118	a(BLM,CRTC3,FANCI,IDH2,NR2F2,PCSK6) 	¬d3p14.2  & dXq28 	 0.42249	Model 1201	GDSC
PANCAN	PF-4708671	null	null	893	84	a8q24.13 	a8q24.13  & ¬a20q13.13 	 0.49534	Model 1201	GDSC
PANCAN	PF-562271	null	null	847	70	BRAF 	¬TP53  & dXp21.1   |  BRAF  & IL-1-UP 	 0.39091	Model 2201	GDSC
PANCAN	PFI-1	null	null	917	84	NRAS 	MLL2  | NCOR2  | d15q14  | JAK-STAT-UP 	 0.46285	Model 4101	GDSC
PANCAN	PHA-665752	null	null	396	60	TGFB-UP 	¬d(SDHD)  & ¬d(POT1)  & ¬d(SRGAP3)  & dXq22.3 	 0.42117	Model 1401	GDSC
PANCAN	PHA-793887	null	null	902	101	MLL2 	MLL2  | TP53BP1  | JAK-STAT-UP  | MAPK_only-DOWN 	 0.36643	Model 4101	GDSC
PANCAN	Phenformin	null	null	892	101	MLL2 	¬d(CHD3,GPS2,TP53)  & dXq28  & ¬d20p12.1 	 0.43567	Model 1301	GDSC
PANCAN	PI-103	null	null	893	77	MLL2 	¬TP53  & ¬a(CCT5,TERT,TRIO)  & ¬d3p14.2  & ¬TGFB-UP 	 0.37671	Model 1401	GDSC
PANCAN	PIK-93	null	null	900	153	JAK-STAT-UP 	MLL2  | JAK-STAT-UP  | MAPK_only-DOWN 	 0.31112	Model 3101	GDSC
PANCAN	piperlongumine	null	null	914	96	a(EGFR) 	¬a(CCND1,CTTN)  & a(EGFR)   |  BRCA2  & d(ARFGAP3) 	 0.42229	Model 2201	GDSC
PANCAN	PLX4720	null	null	835	91	BRAF 	BRAF 	 0.15294	Model 1101	GDSC
PANCAN	PLX4720__rescreen	null	null	904	120	BRAF 	BRAF 	 0.16033	Model 1101	GDSC
PANCAN	PXD101_Belinostat	null	null	875	77	MAPK_only-DOWN 	¬d(ARID1B,MAP3K4,MLLT4)  & dXq22.3  & ¬d(ERCC3) 	 0.43653	Model 1301	GDSC
PANCAN	Pyrimethamine	null	null	391	37	MAPK_only-DOWN 	GATA3  | MECOM  | d4q22.1  | MAPK_only-DOWN 	 0.39748	Model 4101	GDSC
PANCAN	QL-VIII-58	null	null	489	30	d12p13.31 	¬TP53  & ¬a(MYC)  & ¬d3p14.2  & ¬a(MYCN) 	 0.45003	Model 1401	GDSC
PANCAN	QL-X-138	null	null	889	88	MLL2 	MLL2  | MAPK_only-DOWN 	 0.34303	Model 2101	GDSC
PANCAN	QL-XI-92	null	null	902	331	JAK-STAT-UP 	MLL2  | JAK-STAT-UP  | MAPK_only-DOWN 	 0.40699	Model 3101	GDSC
PANCAN	QL-XII-47	null	null	900	54	TNFa-DOWN 	¬d(CHD9,CNOT1,CYLD,MMP2,NUP93)  & ¬d(FAT1,IRF2)  & dXq21.33  & ¬d20p12.1 	 0.3972	Model 1401	GDSC
PANCAN	QL-XII-61	null	null	465	137	JAK-STAT-UP 	MACF1  | JAK-STAT-UP  | TLR-UP  | MAPK_PI3K-DOWN 	 0.43469	Model 4101	GDSC
PANCAN	QS11	null	null	854	63	d(CHD9,CNOT1,CYLD,MMP2,NUP93) 	MLL2  & ¬d8p23.3   |  ¬d(BNC2,CDKN2A,JAK2,PSIP1)  & dXp11.3 	 0.39769	Model 2201	GDSC
PANCAN	Rapamycin	null	null	354	66	PI3K_only-UP 	¬d(LARP4B)  & d(SYNCRIP,ZNF292)  & ¬d(RPL22)  & ¬d17p13.2 	 0.40445	Model 1401	GDSC
PANCAN	RDEA119	null	null	827	84	BRAF 	BRAF  | NRAS  | JAK-STAT-UP 	 0.22894	Model 3101	GDSC
PANCAN	RDEA119__rescreen	null	null	867	108	BRAF 	BRAF  | NRAS  | JAK-STAT-UP 	 0.232	Model 3101	GDSC
PANCAN	RO-3306	null	null	836	106	d(ERCC3) 	TP53  & ¬d(APC)  & ¬d17p11.2  & dXp11.3 	 0.46179	Model 1401	GDSC
PANCAN	Roscovitine	null	null	387	35	d(PCDH18) 	d(CASP1),d11q22.3  & d8p23.3   |  MLL2  & ¬a(CCT5,TERT,TRIO) 	 0.46839	Model 2201	GDSC
PANCAN	rTRAIL	null	null	906	253	BRAF 	¬d8p23.1  & ¬d(FAT1,IRF2)  & dXq21.33 	 0.47139	Model 1301	GDSC
PANCAN	Ruxolitinib	null	null	902	113	JAK-STAT-UP 	JAK-STAT-UP 	 0.3996	Model 1101	GDSC
PANCAN	Salubrinal	null	null	388	23	MLL2 	¬d(FAT1,IRF2)  & ¬d(SRGAP3)  & dXq28 	 0.37272	Model 1301	GDSC
PANCAN	SB_216763	null	null	733	91	a(MYCN) 	¬d(SYNCRIP,ZNF292)  & dXq22.3 	 0.3852	Model 1201	GDSC
PANCAN	SB-505124	null	null	914	92	d10q25.3 	¬KRAS  & ¬TP53  & ¬d18q22.1  & ¬d(SDHD) 	 0.47759	Model 1401	GDSC
PANCAN	SB52334	null	null	899	107	d(ARID1B,MAP3K4,MLLT4) 	BRAF  | EWSR1-FLI1  | MLL3  | TLR-DOWN 	 0.41914	Model 4101	GDSC
PANCAN	SB590885	null	null	816	126	BRAF 	BRAF 	 0.20692	Model 1101	GDSC
PANCAN	SB-715992	null	null	902	36	d(BMPR1A,FAS,PTEN) 	d(BMPR1A,FAS,PTEN)  & ¬d(FAT1,IRF2)   |  PTEN  & d(BNC2,CDKN2A,JAK2,PSIP1) 	 0.46911	Model 2201	GDSC
PANCAN	SGC0946	null	null	896	87	PTEN 	¬d(FAT1,IRF2)  & dXp21.1  & ¬d(ERCC3) 	 0.43148	Model 1301	GDSC
PANCAN	Shikonin	null	null	860	85	BRAF 	¬TP53  & ¬d(MED17)  & d(BNC2,CDKN2A,JAK2,PSIP1) 	 0.48805	Model 1301	GDSC
PANCAN	SL_0101-1	null	null	822	76	a(MYC) 	¬ARAP3  & a(MYC)   |  d19q13.33  & IL-1-DOWN 	 0.40248	Model 2201	GDSC
PANCAN	SN-38	null	null	917	61	MLL2 	EWSR1-FLI1  | MLL2  | TLR-DOWN 	 0.41095	Model 3101	GDSC
PANCAN	SNX-2112	null	null	892	46	JAK-STAT-UP 	¬TP53  & ¬a(MYC)  & ¬a(IL7R)  & ¬d3p14.2 	 0.27812	Model 1401	GDSC
PANCAN	Sorafenib	null	null	393	31	d12p12.3 	FLT3  | d12p12.3 	 0.41912	Model 2101	GDSC
PANCAN	STF-62247	null	null	898	141	JAK-STAT-UP 	d(CASP1),d11q22.3  | JAK-STAT-UP  | MAPK_only-DOWN  | MAPK_PI3K-DOWN 	 0.35128	Model 4101	GDSC
PANCAN	S-Trityl-L-cysteine	null	null	387	17	d(GNAQ,NTRK2,PCSK5,TJP2) 	¬d3p14.2  & ¬d(CHD3,GPS2,TP53)  & dXq28 	 0.43113	Model 1301	GDSC
PANCAN	Sunitinib	null	null	388	26	FLT3 	¬d(SDHD)  & ¬d3p14.2  & dXq22.3 	 0.38379	Model 1301	GDSC
PANCAN	T0901317	null	null	895	111	MLL2 	MLL2  | d7p12.1  | JAK-STAT-UP 	 0.29003	Model 3101	GDSC
PANCAN	TAK-715	null	null	904	75	JAK-STAT-UP 	¬d3p14.2  & dXq28 	 0.40708	Model 1201	GDSC
PANCAN	Tamoxifen	null	null	914	103	CREBBP 	CREBBP  | MLL  | PIK3CA  | MAPK_only-DOWN 	 0.41981	Model 4101	GDSC
PANCAN	Temozolomide	null	null	896	97	TLR-UP 	¬APC  & ¬a(MYC)  & ¬d(BNC2,CDKN2A,JAK2,PSIP1)  & ¬d(FAT1,IRF2) 	 0.38134	Model 1401	GDSC
PANCAN	Temsirolimus	null	null	822	114	PTEN 	MYH11  | a(ACTB,CARD11,PMS2,RAC1)  | d6q23.3  | MAPK_only-DOWN 	 0.43539	Model 4101	GDSC
PANCAN	TG101348	null	null	902	113	JAK-STAT-UP 	¬d(SMAD4),d18q21.2  & ¬d(ARID1B,MAP3K4,MLLT4)  & dXq21.33  & ¬d20p12.1 	 0.37985	Model 1401	GDSC
PANCAN	TGX221	null	null	390	56	PTEN 	MGA  | PTEN  | d8p21.1  | H2O2-UP 	 0.48654	Model 4101	GDSC
PANCAN	Thapsigargin	null	null	840	54	a(MYC) 	dXp11.3  & ¬dXq28 	 0.41695	Model 1201	GDSC
PANCAN	THZ-2-102-1	null	null	883	76	JAK-STAT-UP 	EWSR1-X  | MLL2  | JAK-STAT-UP  | MAPK_only-DOWN 	 0.33709	Model 4101	GDSC
PANCAN	THZ-2-49	null	null	897	37	BRAF 	¬d8p23.3  & ¬d16q23.1  & d(SYNCRIP,ZNF292) 	 0.3486	Model 1301	GDSC
PANCAN	Tipifarnib	null	null	852	100	MLL2 	¬TP53  & ¬d8p23.3  & ¬a3q26.1  & ¬d(RPL22) 	 0.41971	Model 1401	GDSC
PANCAN	TL-1-85	null	null	900	80	JAK-STAT-UP 	ARID4A  & ¬PIK3R1   |  ¬d3p14.2  & dXq28 	 0.26795	Model 2201	GDSC
PANCAN	TL-2-105	null	null	904	131	JAK-STAT-UP 	¬d3p14.2  & dXq28 	 0.37704	Model 1201	GDSC
PANCAN	TPCA-1	null	null	900	112	JAK-STAT-UP 	MLL2  | JAK-STAT-UP  | TLR-UP 	 0.32479	Model 3101	GDSC
PANCAN	Trametinib	null	null	883	284	BRAF 	BRAF  | KRAS  | NRAS 	 0.24008	Model 3101	GDSC
PANCAN	Tubastatin_A	null	null	897	301	JAK-STAT-UP 	MLL2  | NRAS  | JAK-STAT-UP  | MAPK_only-DOWN 	 0.37242	Model 4101	GDSC
PANCAN	TW_37	null	null	905	80	PTEN 	NCOR1  | PTEN  | SMARCA4  | TLR-DOWN 	 0.30998	Model 4101	GDSC
PANCAN	UNC0638	null	null	917	72	MAPK_PI3K-DOWN 	JAK-STAT-UP  | Wnt-UP  | MAPK_PI3K-DOWN  | TLR-DOWN 	 0.50031	Model 4101	GDSC
PANCAN	UNC1215	null	null	897	98	MLL2 	¬d(BNC2,CDKN2A,JAK2,PSIP1)  & dXp11.3   |  ¬d(CASP1),d11q22.3  & d17p13.1 	 0.41725	Model 2201	GDSC
PANCAN	Vinblastine	null	null	834	53	MLL2 	¬d(FAT1,IRF2)  & JAK-STAT-UP   |  ¬TP53  & d16q23.1 	 0.46059	Model 2201	GDSC
PANCAN	Vinorelbine	null	null	864	55	BRAF 	d16q23.1  & ¬d(ATRX) 	 0.45296	Model 1201	GDSC
PANCAN	Vismodegib	null	null	834	104	MLL2 	¬d8p23.3  & ¬d(SRGAP3)  & dXq21.33  & ¬d21q11.2 	 0.43642	Model 1401	GDSC
PANCAN	VNLG124	null	null	897	126	JAK-STAT-UP 	CDKN1B  | TET2  | JAK-STAT-UP  | MAPK_only-DOWN 	 0.27355	Model 4101	GDSC
PANCAN	Vorinostat	null	null	835	54	JAK-STAT-UP 	¬TP53  & dXp22.32 	 0.41712	Model 1201	GDSC
PANCAN	VX-11e	null	null	900	114	BRAF 	BRAF  | NRAS  | JAK-STAT-UP 	 0.28325	Model 3101	GDSC
PANCAN	VX-680	null	null	383	82	MLL2 	¬d(POT1)  & ¬d4q22.1  & dXq28  & ¬d(PABPC3,SACS,ZMYM2) 	 0.44535	Model 1401	GDSC
PANCAN	VX-702	null	null	831	93	JAK-STAT-UP 	HLA-A  | JAK-STAT-UP  | TLR-UP  | TNFa-DOWN 	 0.44645	Model 4101	GDSC
PANCAN	WH-4-023	null	null	386	83	BCR-ABL 	BCR-ABL  | CREBBP  | NF2 	 0.45062	Model 3101	GDSC
PANCAN	WZ-1-84	null	null	388	53	d21q11.2 	TP53  & d18q22.1  & ¬dXq22.3 	 0.44998	Model 1301	GDSC
PANCAN	WZ3105	null	null	902	66	JAK-STAT-UP 	JAK-STAT-UP  | MAPK_only-DOWN 	 0.35352	Model 2101	GDSC
PANCAN	XAV_939	null	null	905	94	a(MECOM) 	a(MECOM)  | d20p12.1 	 0.50353	Model 2101	GDSC
PANCAN	XL-184	null	null	900	87	JAK-STAT-UP 	JAK-STAT-UP  & ¬IL-1-DOWN   |  ¬d(SYNCRIP,ZNF292)  & dXq22.3 	 0.42741	Model 2201	GDSC
PANCAN	XL-880	null	null	897	74	JAK-STAT-UP 	¬d3p14.2  & dXq22.3   |  ¬ACVR2A  & MLL-AFF1 	 0.40562	Model 2201	GDSC
PANCAN	XMD11-85h	null	null	487	42	JAK-STAT-UP 	d(ARID1B,MAP3K4,MLLT4)  | JAK-STAT-UP 	 0.36116	Model 2101	GDSC
PANCAN	XMD13-2	null	null	901	92	MLL2 	MLL2  | JAK-STAT-UP  | IL-1-DOWN  | MAPK_only-DOWN 	 0.37849	Model 4101	GDSC
PANCAN	XMD14-99	null	null	902	166	JAK-STAT-UP 	CREBBP  | JAK-STAT-UP  | MAPK_only-DOWN 	 0.38096	Model 3101	GDSC
PANCAN	XMD15-27	null	null	902	137	JAK-STAT-UP 	¬d(SRGAP3)  & dXq28 	 0.45583	Model 1201	GDSC
PANCAN	XMD8-85	null	null	387	39	MAPK_only-DOWN 	¬d(FAT1,IRF2)  & dXq28  & ¬d(RB1) 	 0.41674	Model 1301	GDSC
PANCAN	XMD8-92	null	null	488	39	EP300 	EP300  | JAK-STAT-UP 	 0.45401	Model 2101	GDSC
PANCAN	Y-39983	null	null	900	348	JAK-STAT-UP 	MLL2  | JAK-STAT-UP  | MAPK_only-DOWN 	 0.36811	Model 3101	GDSC
PANCAN	YK_4-279	null	null	783	70	PTEN 	¬d18q22.1  & d3p14.2 	 0.45971	Model 1201	GDSC
PANCAN	YM155	null	null	869	15	d(PCDH18) 	d(FAT1,IRF2)  & ¬dXp22.32   |  a(CCNE1)  & d16q23.1 	 0.50914	Model 2201	GDSC
PANCAN	YM201636	null	null	900	74	MAPK_only-DOWN 	EWSR1-FLI1  | d7p12.1  | Wnt-UP  | MAPK_only-DOWN 	 0.31714	Model 4101	GDSC
PANCAN	ZG-10	null	null	487	41	d(CHD9,CNOT1,CYLD,MMP2,NUP93) 	¬KRAS  & ¬a(MYC)  & ¬d8p21.1  & d(SYNCRIP,ZNF292) 	 0.40967	Model 1401	GDSC
PANCAN	Zibotentan_ZD4054	null	null	900	93	JAK-STAT-UP 	EZH2  | JAK-STAT-UP  | MAPK_only-DOWN 	 0.37943	Model 3101	GDSC
PANCAN	Z-LLNle-CHO	null	null	388	28	FN1 	¬a(ACTB,CARD11,PMS2,RAC1)  & a(AKAP9)   |  d16q23.1  & d(BNC2,CDKN2A,JAK2,PSIP1) 	 0.45193	Model 2201	GDSC
PANCAN	ZM-447439	null	null	788	84	XRN1 	XRN1  | JAK-STAT-UP  | MAPK_only-DOWN 	 0.36187	Model 3101	GDSC
PANCAN	ZSTK474	null	null	902	99	MAPK_only-DOWN 	ASXL1  | MLL2  | JAK-STAT-UP  | MAPK_only-DOWN 	 0.33037	Model 4101	GDSC
SKCM	17-AAG	null	null	42	8	d10q23.31 	d10q23.31 	 0.42434	Model 1101	GDSC
SKCM	_5Z_-7-Oxozeaenol	null	null	49	30	a(FOXP1,MITF) 	a(FOXP1,MITF)  | d10q23.31  | TGFB-DOWN 	 0.2389	Model 3101	GDSC
SKCM	A-770041	null	null	17	6	TGFB-UP 	TGFB-UP  | TGFB-DOWN 	 0.45164	Model 2101	GDSC
SKCM	ABT-888	null	null	45	7	d16q23.1 	d16q23.1  & ¬d10q26.3 	 0.51954	Model 1201	GDSC
SKCM	AMG-706	null	null	42	8	BAZ2B 	BAZ2B 	 0.5135	Model 1101	GDSC
SKCM	AS605240	null	null	46	15	EZH2 	¬TP53  & ¬d16q23.1  & ¬a(FOXP1,MITF)  & ¬Wnt-DOWN 	 0.26181	Model 1401	GDSC
SKCM	ATRA	null	null	45	5	d4p15.2 	d4p15.2 	 0.52893	Model 1101	GDSC
SKCM	AUY922	null	null	48	5	TGFB-UP 	¬BPTF  & ¬EP300  & TGFB-UP 	 0.49476	Model 1301	GDSC
SKCM	AZD6244	null	null	49	36	a(FOXP1,MITF) 	¬BPTF  & ¬PTEN  & ¬d16q23.1  & ¬a(KRAS) 	 0.3129	Model 1401	GDSC
SKCM	AZD6482	null	null	46	5	PTEN 	¬NRAS  & ¬d10q23.31  & VEGF-UP  & ¬TGFB-DOWN 	 0.39436	Model 1401	GDSC
SKCM	Bleomycin__50_uM	null	null	52	5	TGFB-DOWN 	¬CDKN2A  & ¬PLCB1  & ¬d10q26.3  & VEGF-UP 	 0.17929	Model 1401	GDSC
SKCM	BMN-673	null	null	51	5	Wnt-DOWN 	¬d(BNC2,CDKN2A,JAK2,PSIP1)  & VEGF-UP 	 0.096439	Model 1201	GDSC
SKCM	BMS-536924	null	null	52	7	BAZ2B 	BAZ2B 	 0.5	Model 1101	GDSC
SKCM	BMS-754807	null	null	49	7	NRAS 	¬d10q23.31  & TGFB-UP   |  NRAS  & d(BNC2,CDKN2A,JAK2,PSIP1) 	 0.4893	Model 2201	GDSC
SKCM	Bortezomib	null	null	16	5	CLASP2 	CLASP2 	 0.5	Model 1101	GDSC
SKCM	Bosutinib	null	null	45	5	EP300 	EP300 	 0.5	Model 1101	GDSC
SKCM	Bryostatin_1	null	null	47	10	NCOR1 	NCOR1  | STK11  | d(CASP1) 	 0.5055	Model 3101	GDSC
SKCM	CCT007093	null	null	49	5	d15q15.1 	d16p13.3  | d15q15.1  | a(MYC)  | IL-1-UP 	 0.50804	Model 4101	GDSC
SKCM	CEP-701	null	null	45	7	ELF1 	¬NF1  & ¬PTEN  & TP53  & ¬a(FOXP1,MITF) 	 0.13017	Model 1401	GDSC
SKCM	Cetuximab	null	null	48	6	CTNNB1 	¬ELF1  & TP53  & ¬d(BNC2,CDKN2A,JAK2,PSIP1)  & ¬VEGF-UP 	 0.38567	Model 1401	GDSC
SKCM	CHIR-99021	null	null	49	6	d16q23.1 	d16q23.1 	 0.54002	Model 1101	GDSC
SKCM	CI-1040	null	null	45	27	d17p13.2 	¬EZH2  & ¬PTEN  & d(BNC2,CDKN2A,JAK2,PSIP1)  & ¬MAPK_only-UP 	 0.52973	Model 1401	GDSC
SKCM	Cisplatin	null	null	45	5	EP300 	¬ZNF638  & TGFB-UP  & ¬TNFa-UP  & ¬Wnt-DOWN 	 0.40625	Model 1401	GDSC
SKCM	CX-5461	null	null	50	21	TGFB-UP 	EZH2  | d14q32.2  | TGFB-UP 	 0.39216	Model 3101	GDSC
SKCM	Dabrafenib	null	null	44	34	BRAF 	BRAF  & ¬MAPK_only-UP 	 0.18342	Model 1201	GDSC
SKCM	Dasatinib	null	null	17	10	TGFB-UP 	d(BNC2,CDKN2A,JAK2,PSIP1)  & ¬d11q24.2   |  MECOM  & ¬d22q13.31 	 0.28454	Model 2201	GDSC
SKCM	Doxorubicin	null	null	49	6	TGFB-UP 	¬ZNF638  & ¬H2O2-UP  & TGFB-UP 	 0.44484	Model 1301	GDSC
SKCM	Embelin	null	null	49	9	d10q23.31 	¬d16p13.3  & d10q23.31  & ¬H2O2-UP 	 0.39091	Model 1301	GDSC
SKCM	EX-527	null	null	50	5	d14q32.2 	¬NF1  & TP53  & ¬a(FOXP1,MITF)  & ¬VEGF-UP 	 0.33248	Model 1401	GDSC
SKCM	FH535	null	null	49	16	d(CASP1) 	¬ARID1B  & ¬STK11  & d(CASP1) 	 0.49011	Model 1301	GDSC
SKCM	FMK	null	null	47	7	PTEN 	EP300  | FAM123B  | PTEN  | TAOK1 	 0.45846	Model 4101	GDSC
SKCM	FR-180204	null	null	50	9	MCM8 	ARHGAP29  | EP300  | MLL3  | TAOK1 	 0.5	Model 4101	GDSC
SKCM	FTI-277	null	null	49	8	HDAC9 	¬TP53  & d16q23.1 	 0.53002	Model 1201	GDSC
SKCM	GSK-1904529A	null	null	49	6	ARID2 	¬BRAF  & d16q23.1   |  NF1  & ¬TP53 	 0.35438	Model 2201	GDSC
SKCM	GSK269962A	null	null	52	5	TGFB-UP 	CLASP2  | EP300  | d16p13.3  | TNFa-UP 	 0.28172	Model 4101	GDSC
SKCM	GW_441756	null	null	44	6	BAZ2B 	BAZ2B 	 0.5	Model 1101	GDSC
SKCM	HG-6-64-1	null	null	47	5	Wnt-DOWN 	Wnt-DOWN 	 0.54632	Model 1101	GDSC
SKCM	IOX2	null	null	52	8	a(NOTCH2) 	BRAF  & TP53  & ¬d16q23.1  & ¬Wnt-DOWN 	 0.49856	Model 1401	GDSC
SKCM	JNK-9L	null	null	48	6	BAP1 	NRAS  & d(BNC2,CDKN2A,JAK2,PSIP1)  & ¬d(CASP1) 	 0.52165	Model 1301	GDSC
SKCM	JNK_Inhibitor_VIII	null	null	42	7	BAZ2B 	ANK3  | BAZ2B  | EP300 	 0.5	Model 3101	GDSC
SKCM	JQ12	null	null	48	7	EZH2 	EZH2 	 0.51326	Model 1101	GDSC
SKCM	KIN001-260	null	null	50	10	d10q26.3 	EZH2  & ¬PCDH18   |  d10q26.3  & VEGF-UP 	 0.53817	Model 2201	GDSC
SKCM	KIN001-266	null	null	50	5	RAC1 	EZH2  & ¬LRP6  & ¬MAP3K4 	 0.5	Model 1301	GDSC
SKCM	LAQ824	null	null	49	5	AHCTF1 	BRAF  & ¬TP53  & ¬d16q23.1  & ¬VEGF-UP 	 0.43302	Model 1401	GDSC
SKCM	Lenalidomide	null	null	45	5	TGFB-UP 	¬NRAS  & PLCB1   |  d(BNC2,CDKN2A,JAK2,PSIP1)  & TGFB-UP 	 0.5021	Model 2201	GDSC
SKCM	Masitinib	null	null	50	8	ARID2 	d(BNC2,CDKN2A,JAK2,PSIP1)  & H2O2-UP   |  ARID2  & ¬d16q23.1 	 0.17018	Model 2201	GDSC
SKCM	MG-132	null	null	17	7	PLCB1 	¬ARID2  & ¬MECOM  & d(BNC2,CDKN2A,JAK2,PSIP1) 	 0.2628	Model 1301	GDSC
SKCM	Nilotinib	null	null	44	4	BAZ2B 	BAZ2B 	 0.5	Model 1101	GDSC
SKCM	NSC-87877	null	null	49	10	CDKN2A 	BPTF  | MAP3K4  | TGFB-DOWN  | Wnt-DOWN 	 0.47434	Model 4101	GDSC
SKCM	Nutlin-3a	null	null	42	23	ARID2 	¬TP53  & ¬d(CASP1)   |  CDKN2A  & d(BNC2,CDKN2A,JAK2,PSIP1) 	 0.18384	Model 2201	GDSC
SKCM	NVP-BHG712	null	null	50	12	EZH2 	EZH2 	 0.50313	Model 1101	GDSC
SKCM	Obatoclax_Mesylate	null	null	49	16	EZH2 	¬ARHGAP29  & EZH2   |  ¬d10q23.31  & TGFB-UP 	 0.42639	Model 2201	GDSC
SKCM	Olaparib	null	null	45	6	d16q23.1 	BAZ2B  | EP300  | RB1  | d16q23.1 	 0.17222	Model 4101	GDSC
SKCM	OSI-906	null	null	48	5	ARID2 	EP300  | NCOR1  | IL-1-UP 	 0.5	Model 4101	GDSC
SKCM	Pazopanib	null	null	49	6	H2O2-UP 	DHX15  | FAM123B  | PI3K_only-DOWN 	 0.50987	Model 3101	GDSC
SKCM	PD-0325901	null	null	40	30	NRAS 	¬PCDH18  & ¬PTEN  & d(BNC2,CDKN2A,JAK2,PSIP1) 	 0.27808	Model 1301	GDSC
SKCM	PF-4708671	null	null	49	6	FAM123B 	ELF1  | FAM123B  | PTEN  | ZNF638 	 0.51837	Model 4101	GDSC
SKCM	PFI-1	null	null	52	5	PTEN 	CLSPN  | PTEN 	 0.47438	Model 2101	GDSC
SKCM	Phenformin	null	null	49	6	EZH2 	STK11  & d(BNC2,CDKN2A,JAK2,PSIP1)   |  EZH2  & ¬PCDH18 	 0.50409	Model 2201	GDSC
SKCM	piperlongumine	null	null	52	6	TGFB-UP 	¬a(FOXP1,MITF)  & TGFB-UP  & ¬Wnt-DOWN 	 0.51428	Model 1301	GDSC
SKCM	PLX4720	null	null	42	27	a(FOXP1,MITF) 	d(PAX5)  | a(FOXP1,MITF)  | TGFB-UP  | TGFB-DOWN 	 0.28779	Model 4101	GDSC
SKCM	PLX4720__rescreen	null	null	52	36	TGFB-DOWN 	BRAF  & ¬d10q26.3  & ¬H2O2-UP 	 0.17679	Model 1301	GDSC
SKCM	QL-XI-92	null	null	50	13	PI3K_only-DOWN 	PI3K_only-DOWN 	 0.30621	Model 1101	GDSC
SKCM	QL-XII-61	null	null	31	11	VEGF-UP 	¬PLCB1  & ¬TP53  & ¬d16q23.1  & ¬Wnt-DOWN 	 0.52495	Model 1401	GDSC
SKCM	RDEA119	null	null	40	23	a(FOXP1,MITF) 	a(FOXP1,MITF) 	 0.36062	Model 1101	GDSC
SKCM	RDEA119__rescreen	null	null	48	33	a(FOXP1,MITF) 	a(FOXP1,MITF) 	 0.43614	Model 1101	GDSC
SKCM	rTRAIL	null	null	52	20	TGFB-UP 	PTEN  | d17p13.2  | TGFB-UP 	 0.37722	Model 3101	GDSC
SKCM	SB_216763	null	null	41	5	TGFB-UP 	TGFB-UP 	 0.50635	Model 1101	GDSC
SKCM	SB-505124	null	null	52	8	CEP290 	CEP290  | MLL3  | PCDH18  | d4p15.2 	 0.41422	Model 4101	GDSC
SKCM	SB52334	null	null	50	12	d14q32.2 	RAC1  | d14q32.2 	 0.56621	Model 2101	GDSC
SKCM	SB590885	null	null	38	27	a(FOXP1,MITF) 	BRAF  & ¬MAPK_only-UP  & ¬TNFa-UP 	 0.28168	Model 1301	GDSC
SKCM	SGC0946	null	null	49	5	Wnt-DOWN 	VEGF-UP  & Wnt-DOWN 	 0.53875	Model 1201	GDSC
SKCM	Shikonin	null	null	49	8	d16q23.1 	¬MECOM  & ¬TP53  & d16q23.1  & ¬d10q23.33 	 0.54085	Model 1401	GDSC
SKCM	Temsirolimus	null	null	45	7	BAZ2B 	BAZ2B  | EP300 	 0.53303	Model 2101	GDSC
SKCM	TGX221	null	null	17	5	ZNF638 	BRAF  & ¬a(MDM2,NUP107)  & ¬TGFB-DOWN  & ¬Wnt-DOWN 	 0.54849	Model 1401	GDSC
SKCM	Tipifarnib	null	null	48	5	ARID2 	ANK3  & d17p13.2   |  ARID2  & ¬NF1 	 0.42283	Model 2201	GDSC
SKCM	Trametinib	null	null	48	43	a(FOXP1,MITF) 	¬KDM6A  & ¬MAPK_only-UP  & ¬TNFa-UP  & ¬Wnt-DOWN 	 0.36264	Model 1401	GDSC
SKCM	Tubastatin_A	null	null	50	12	EZH2 	EZH2  | TGFB-UP 	 0.50157	Model 2101	GDSC
SKCM	TW_37	null	null	49	8	CDKN2A 	CEP290  | MAP3K4  | PTEN  | a(MYC) 	 0.39893	Model 4101	GDSC
SKCM	UNC0638	null	null	52	6	a(NOTCH2) 	TP53  & ¬d11q24.2  & ¬a(MYC) 	 0.24146	Model 1301	GDSC
SKCM	Vismodegib	null	null	45	8	EP300 	BRAF  & ¬TP53  & TGFB-UP 	 0.4593	Model 1301	GDSC
SKCM	VX-11e	null	null	50	20	EZH2 	EP300  | EZH2  | Wnt-DOWN 	 0.43812	Model 3101	GDSC
SKCM	VX-702	null	null	44	6	d16q23.1 	d16q23.1  | a(MYC) 	 0.18126	Model 3101	GDSC
SKCM	XMD14-99	null	null	50	6	NCOR1 	NCOR1 	 0.5009	Model 1101	GDSC
SKCM	Y-39983	null	null	50	6	TGFB-UP 	TP53  & ¬d16q23.1  & ¬a(FOXP1,MITF)  & ¬d(CASP1) 	 0.38321	Model 1401	GDSC
STAD	17-AAG	null	null	22	5	PIK3CA 	ATR  | MYH9  | d19p13.2 	 0.49209	Model 3101	GDSC
STAD	ABT-263	null	null	22	6	CTNNB1 	¬NF1  & ¬d6p25.2  & ¬d20p12.1  & ¬d(FAT1,IRF2) 	 0.39279	Model 1401	GDSC
STAD	Afatinib	null	null	21	5	d(MAP2K4) 	¬APC  & ¬ARID1A  & ¬d6q25.1  & d3p14.2 	 0.16594	Model 1401	GDSC
STAD	AKT_inhibitor_VIII	null	null	20	5	PIK3CA 	¬d(CDKN2A)  & d20p12.1 	 0.34245	Model 1201	GDSC
STAD	CX-5461	null	null	20	10	d16q23.1 	d16q23.1  & ¬PI3K_only-DOWN 	 0.1662	Model 1201	GDSC
STAD	EHT_1864	null	null	24	5	d19p13.2 	¬ARID2  & ¬d6p25.3  & ¬a(MET)  & ¬d4q22.1 	 0.31226	Model 1401	GDSC
STAD	GSK-1904529A	null	null	19	6	ARID1A 	ARID1A  & ¬d16q23.1 	 0.54449	Model 1201	GDSC
STAD	GSK690693	null	null	19	6	IL-1-DOWN 	MET  | TLR-UP  | IL-1-DOWN 	 0.44254	Model 3101	GDSC
STAD	MK-2206	null	null	21	5	d(MAP2K4) 	MYH9  | TP53BP1  | d(MAP2K4)  | d(PTEN) 	 0.39699	Model 4101	GDSC
STAD	PF-4708671	null	null	24	5	a(MYC) 	d19p13.2  & ¬a(MET)   |  a(MYC)  & ¬a(FOXA2) 	 0.1627	Model 2201	GDSC
STAD	QL-XI-92	null	null	20	5	a(MYC) 	a(MYC) 	 0.45192	Model 1101	GDSC
STAD	rTRAIL	null	null	19	9	¬d16q23.1 	¬CTNNB1  & ¬d16q23.1  & ¬d14q11.2 	 0.24383	Model 1301	GDSC
STAD	Trametinib	null	null	20	5	d22q13.31 	d22q13.31 	 0.37657	Model 1101	GDSC
STAD	Y-39983	null	null	20	7	¬TP53 	¬TP53  | a(STK4)  | d(PTEN) 	 0.22979	Model 3101	GDSC
THCA	_5Z_-7-Oxozeaenol	null	null	15	7	PIK3CA 	BRAF  & ¬NF2 	 0.13753	Model 1201	GDSC
THCA	AZD6244	null	null	14	6	PIK3CA 	BRAF  & ¬NF2  & ¬IL-1-UP 	 0.15282	Model 1301	GDSC
THCA	Bleomycin__50_uM	null	null	15	5	CREBBP 	NF2  | PIK3CA  | SMARCA4 	 0.36795	Model 4101	GDSC
THCA	Bryostatin_1	null	null	15	5	d(FANCG,PAX5) 	¬BRAF  & ¬NRAS  & ¬H2O2-UP 	 0.14031	Model 1301	GDSC
THCA	CHIR-99021	null	null	15	6	IL-1-UP 	¬d(FANCG,PAX5)  & PI3K_only-DOWN   |  IL-1-UP 	 0.5	Model 2201	GDSC
THCA	CI-1040	null	null	12	5	PIK3CA 	KRAS  | NRAS  | PIK3CA  | SMARCA4 	 0.33522	Model 4101	GDSC
THCA	CX-5461	null	null	15	6	NRAS 	CREBBP  | NRAS 	 0.54203	Model 2101	GDSC
THCA	Dabrafenib	null	null	15	8	BRAF 	KRAS  | BRAF 	 0.00098641	Model 2101	GDSC
THCA	FTI-277	null	null	15	5	CREBBP 	¬d(FANCG,PAX5)  & ¬BRAF  & ¬NRAS  & ¬H2O2-UP 	 0.32424	Model 1401	GDSC
THCA	IOX2	null	null	15	6	NF2 	NF2  | SMARCA4  | TGFB-UP  | PI3K_only-DOWN 	 0.5	Model 4101	GDSC
THCA	PD-0325901	null	null	12	5	NRAS 	NRAS  & ¬TGFB-DOWN   |  BRAF  & ¬IL-1-UP 	 0.32652	Model 2201	GDSC
THCA	PLX4720	null	null	13	5	BRAF 	BRAF  & ¬NF2 	 0.029607	Model 1201	GDSC
THCA	PLX4720__rescreen	null	null	15	7	BRAF 	BRAF  & ¬NF2 	 0.10641	Model 1201	GDSC
THCA	RDEA119__rescreen	null	null	13	5	PIK3CA 	BRAF  & ¬IL-1-UP   |  PTEN  & ¬NF1 	 0.14327	Model 2201	GDSC
THCA	Thapsigargin	null	null	15	6	NRAS 	¬BRAF  & NRAS   |  ¬KRAS  & NF2 	 0.25099	Model 2201	GDSC
THCA	Trametinib	null	null	15	10	BRAF 	BRAF  & ¬NRAS 	 0.1188	Model 1201	GDSC
